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ABSTRACT

A NON-INVASIVE IMAGE BASED SYSTEM FOR EARLY DIAGNOSIS OF
PROSTATE CANCER

Ahmad Abdusalam Firjani Naef

December 04, 2014

Prostate cancer is the second most fatal cancer experienced by American
males [1]. The average American male has a 16.15% chance of developing prostate
cancer, which is 8.38% higher than lung cancer, the second most likely cancer. The
current in-vitro techniques that are based on analyzing a patients blood and urine
have several limitations concerning their accuracy. In addition, the prostate Specific Antigen (PSA) blood-based test, has a high chance of false positive diagnosis,
ranging from 28%-58%. Yet, biopsy remains the gold standard for the assessment
of prostate cancer, but only as the last resort because of its invasive nature, high
cost, and potential morbidity rates. The major limitation of the relatively small
needle biopsy samples is the higher possibility of producing false positive diagnosis. Moreover, the visual inspection system (e.g., Gleason grading system) is not
quantitative technique and different observers may classify a sample differently,
leading to discrepancies in the diagnosis. As reported in the literature that the
early detection of prostate cancer is a crucial step for decreasing prostate cancer related deaths. Thus, there is an urgent need for developing objective, non-invasive
image based technology for early detection of prostate cancer.

v

The objective of this dissertation is to develop a computer vision methodology, later translated into a clinically usable software tool, which can improve sensitivity and specificity of early prostate cancer diagnosis based on the well-known
hypothesis that malignant tumors are will connected with the blood vessels than
the benign tumors. Therefore, using either Diffusion Weighted Magnetic Resonance imaging (DW-MRI) or Dynamic Contrast Enhanced Magnetic Resonance
Imaging (DCE-MRI), we will be able to interrelate the amount of blood in the
detected prostate tumors by estimating either the Apparent Diffusion Coefficient
(ADC) in the prostate with the malignancy of the prostate tumor or perfusion parameters. We intend to validate this hypothesis by demonstrating that automatic
segmentation of the prostate from either DW-MRI or DCE-MRI after handling its
local motion, provides discriminatory features for early prostate cancer diagnosis.
The proposed CAD system consists of three majors components, the first
two of which constitute new research contributions to a challenging computer
vision problem. The three main components are: (1) A novel Shape-based segmentation approach to segment the prostate from either low contrast DW-MRI or
DCE-MRI data; (2) A novel iso-contours-based non-rigid registration approach to
ensure that we have voxel-on-voxel matches of all data which may be more difficult due to gross patient motion, transmitted respiratory effects, and intrinsic
and transmitted pulsatile effects; and (3) Probabilistic models for the estimated
diffusion and perfusion features for both malignant and benign tumors. Our results showed a 98% classification accuracy using Leave-One-Subject-Out (LOSO)
approach based on the estimated ADC for 30 patients (12 patients diagnosed as
malignant; 18 diagnosed as benign). These results show the promise of the proposed image-based diagnostic technique as a supplement to current technologies
for diagnosing prostate cancer.
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CHAPTER I
PROSTATE ANATOMY AND CURRENT DIAGNOSTIC TECHNIQUES

Prostate cancer is the most common malignancy among men. Despite its
prevalence, Prostate cancer is a curable condition in many cases. In America for
example, the five-year survival rate of prostate cancer for men is 100% among patients diagnosed with localized or regional disease and only 31% among men diagnosed at a distant stage [9]. Mortality often happens when patients are affected
by metastasis of the cancer to the bones. At that stage, surgical and hormonal
treatments are not very effective. Therefore, the early diagnosis and staging of the
disease play an important role in the choice and the success of the treatment.This
chapter provides the background to adequately understand the anatomy of the
prostate, prostate cancer, staging of the prostate cancer, and screening modalities.

A.

PROSTATE ANATOMY

The term prostate means ”to stand in front of ”, which is derived from the
Greek prohistani. This expression was adopted by Herophilus of Alexandria in 335
B.C. to describe the organ located in front of the urinary bladder [3]. The prostate
gland location is illustrated in Figure 1. It measures approximately 4x3x2 cm. The
anterior surface lies at the back of the retropubic space and is connected to the
pubic bone by the puboprostatic ligaments [10].
The prostate is divided into three main zones: the central zone (CZ), the
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FIGURE 1: Schematic illustration of an anatomical view of the lower abdomen area
that contains the prostate (Courtesy of [3]).
peripheral zone (PZ), and the transition zone (TZ), excluding the urethra and periurethral glands (Figure 2). The peripheral zone represents approximately 65% of
the prostatic volume. The second largest part of the prostate is the central zone.
It is represents approximately 25% of the prostatic volume. The third zone of the
prostate is called the transition zone, which represents only 5% to 10% of a typical
prostatic volume. The prostate gland is divided into three zones according to their
function:

• The transition zone (TZ) consists of two independent pear shaped lobes situated laterally on either side of the prostatic urethra together with periurethral
glands. This is the zone where benign prostatic hypertrophy (BPH) occurs.
• The central zone (CZ) surrounds the transitional zone posteriorly and encloses the ejaculatory ducts. It is the zone most commonly affected by inflammatory processes (e.g. prostatitis). In benign prostatic hyperplasia, the
transitional zone and periurethral glands enlarge considerably compressing
the central zone to form a thin layer, the so called surgical pseudocapsule.

2

• The peripheral zone (PZ) is the most posterolateral glandular component of
the prostate. The ratio of peripheral zone to central gland tissue gradually
decreases from the apex to the base of the gland. The peripheral zone can be
compressed and distorted by BPH and it is the site of the majority of prostate
cancers [11].

FIGURE 2: Schematic illustration of the front and side cross-sectional views of the
prostate showing different prostate zones (Courtesy of [4]).

B. CURRENT DIAGNOSTIC TECHNIQUES

Inside the prostate, groups of cells may form benign or malignant tumors
(see Figure 3). The cancerous cells may form within the prostate but grow too
slowly to cause problems. In other cases, cancerous tumors may grow inside the
prostate, then spread [6]. The prostate cancerous cells are characterized as follows:

• Noncancerous cells: These may grow inside the prostate as a man ages. This
condition is called benign prostatic hyperplasia (BPH). These growths often
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FIGURE 3: Illustration of Malignant Tumor (Courtesy of [5]).

squeeze the urethra, causing symptoms such as difficulty urinating.
• Pre-cancerous cells: These cells do not appear normal, but they do not present
all the characteristics of cancerous cells. They can not be felt during a physical exam and they do not produce symptoms.
• Cancerous cells: These form most often in the prostate’s outer tissue. Cancer cells may stay inside the prostate or they may spread to nearby organs
and tissues, such as the bladder and seminal vesicles (local spread) or to
the lymph nodes near the prostate (regional spread). Cancer cells can also
spread through the bloodstream to more distant structures such as the bones
(distant metastasis). Many early-stage tumors do not squeeze the urethra, so
they may not cause symptoms. In some cases, tumors can be felt during an
exam.

1. Staging

Staging is used to classify how far the cancer has spread. Cancer is assigned
to one of four stages as, shown in figure 4:

4

FIGURE 4: The stages of prostate cancer (Courtesy of [6]).

• Stage I: Early cancer that is confined to a microscopic area and is too small to
feel when palpated.
• Stage II: The doctor can palpate the tumor, but it is confined only to the
prostate gland.
• Stage III: The cancer has spread to nearby tissues.
• Stage IV: The cancer has spread to the lymph nodes, bones, lungs or other
areas, distant from the original tumor.
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2.

Treatment

Four types of standard treatment for prostate cancer have been established
[6]:

• Surgery is a first choice if the prostate cancer has not spread outside the gland
(stage I or II cancers). In this surgery, the surgeon removes the entire prostate
gland. This type of surgery is called a radical prostatectomy.
• Radiation therapy uses high-energy radiation, such as x-rays to kill cancer
cells. Radiation is used as the initial treatment for cancers that have grown
outside of the prostate gland and into nearby tissues,it is als used to reduce
the size of the tumor (stage III cancers).
• Hormone therapy prevents testosterone from reaching prostate cancer cells.
This therapy is used if the patient is not able to have surgery or radiation or
if the cancer has grown beyond the prostate gland (stage IV).
• Expectant management, or active surveillance, describes the monitoring of
the prostate cancer with prostate-specific antigen (PSA) blood tests, digital
rectal exams (DREs), and prostate biopsies every three to six months to see
changes. Expectant management is used when it is difficult to interpret if
the cells are malignant or not. Because, the PSA arises from both benign and
malignant epithelial cells, PSA usually increases over time.

3. Diagnostic Techniques

Most men, diagnosed with prostate cancer, have no symptoms and only
find their cancer due to screening. However, in advanced cases of prostate cancer,
there are symptoms such as bladder outlet obstruction, acute urinary retention,
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neurological symptoms of cord compression or pathologic fractures secondary to
bony metastases. The currently used screening tests are as follow:

• Digital Rectal Exam (DRE): The DRE test is carried out by a skilled physician
who manually feels for any abnormalities in the prostate gland through the
rectum. The accuracy of this examination is not high, averaging 39%. Nevertheless, DRE is inexpensive, easy to perform, and can detect most of the
tumors of a sufficient volume. However, the DRE alone can not be relied on
to detect prostate cancer.
• Serum PSA: is considered as the best serum marker in the early detection of
prostate cancer. PSA is an enzyme which is secreted by prostatic cells. PSA
was first identified and purified in the 1970s. However, its widespread use in
clinical urology did not occur until the 1980s. The PSA testing is minimally
invasive, simple and safe. Serum PSA elevation may indicate the presence
of prostatic disease (including prostate cancer, benign prostatic hypertrophy,
urinary retention and prostatitis) or result from prostate manipulation such
as transrectal biopsy and prostatic massage. Elevation of PSA above 4 ng/mL
carries a 22% probability of prostate cancer, and a further increase above
10ng/mL raises the cancer risk to 63% [12–14]. As PSA values rise with
age, there is an agreed cut-off level for different age groups. Although this
is not universally accepted, as men may harbor prostate cancer despite low
levels of serum PSA, the use of an age-specific normal range for PSA values increases the positive predictive value of PSA testing. Table 1 details the
normal range of values according to age.
• PSA Density: is defined as the PSA per unit prostate volume. It is useful to
differentiate between prostate cancer and benign hyperplasia. The prostate
volume can be found from TRUS screening.
• PSA Velocity:is defined as the rate of change of serum PSA with time.

7

• TransRectal UltraSound (TRUS) and TRUS Biopsy: TRUS is used to display
the prostate, visualize the cancer, and guide the needles to obtain biopsies
from the prostate. The most common approaches to biopsies are transrectal
and transperineal (see Figure 6). In the transrectal procedure, a 2D US probe
is equipped with a needle guide to access to the prostate through the rectal
wall [7]. The needle trajectory is aligned with the TRUS image enabling the
visualization of the needle trajectory and placement . Since some lesions are
isoechoic, thus not visible in US images, it is necessary to sample the prostate
in a systematic randomized way. The gland is usually divided into six or
more zones of equal volume and one or more core is randomly collected from
each zone. In initial biopsies, the needles are usually laterally directed to
the peripheral zone, since 70% of the lesions are situated in this area. These
samples are later analyzed in laboratory for evidence of cancerous tissue.
Although a large number of biopsies are done with a transrectal approach,
as explained above, some urologists prefer to use a transperineal approach.
In this case, the image is still acquired by TRUS, but needle insertion is done
through the skin between the scrotum and the anus. This procedure is carried
out with the patient under local or general anaesthesia [15]. The accuracy of
TRUS Biopsy in detecting cancer is in the range of 57% to 76%.
• Gleason score The samples of tissue from the biopsy are graded based on
how it looks under a microscope. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread;
a high Gleason score means the cancer tissue is very different from normal
and the tumor is more likely to spread [12].

The main diagnostic tools for prostate cancer are digital rectal exam (DRE) and
serum concentration using prostate specific antigen (PSA) blood test. If any of the
previous screening modalities suggest any abnormalities, biopsies should be done,
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FIGURE 5: Diagnosing scheme for prostate cancer.
TABLE 1: Outlines normal age-specific PSA
Age group Normal PSA value
> 60

PSA≤ 3

60-69

PSA ≤ 4

> 70

PSA ≤ 5

and then examined by a pathologist. The chart in Figure 5 displays the diagnostic
scheme for prostate cancer [3].

C. Limitation of the Current Diagnostic Techniques

The currently used techniques for diagnosing prostate cancer are clearly unsatisfactory. For example, prostate specific antigen (PSA) screening does not offer
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FIGURE 6: An illustration of Transperineal and transrectal approaches to prostate
biopsy. A thin needle is inserted through the rectum or through the perineum parallel to the urethra to perform the operation, and the procedure is usually directed
by an imaging device (e.g., ultrasound) to help in placing the needle into the right
location (Courtesy of [7])

accurate information about the location and extend of the lesion(s). In addition,
PSA is associated with a high risk of over diagnosis. TRUS Biopsy is widely used
for diagnosis of prostate cancer. However, this technique presents some drawbacks. Because the cores are sampled in a blinded way, without the aid of any
visual references (in particular with respect to 3D space), its very difficult to know
the correct position of the biopsy inside the gland, since the TRUS images have
low signal to noise ratio (SNR) [7, 16]. Therefore, its impossible to sample the exact
same site in a later exam to investigate the development of a small cancer lesion
over time. Furthermore, with the current technique, it is possible to miss the cancer since the exam performs a non-exhaustive systematic search for an invisible
target. This results in a low detection rate of about 30 to 40% in traditional 12core biopsies and even with saturation biopsies with 18-cores similar results have
been obtained [15, 17]. Even after an initial extended biopsy, followed by a second,
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third, and fourth saturation biopsy, prostate cancer was still detected in 18%, 17%,
and 14% of patients, respectively [18]. Being so, a large number of false negatives
are inherent to the process, and a negative result cannot exclude cancer diagnosis.
Patients with maintained suspicions may have to repeat biopsy series. Gleason
scores require biopsies to invasively collect tissue samples. Therefore, despite all
its high costs and morbidity rates, biopsy is still remaining as the golden standard
for diagnosis of prostate cancer. However,it is resort.
On the other hand, imaging tests are favorable since they provide reliable
information about the size and shape of prostate gland and can localize the cancer
foci, which would improve the accuracy of diagnosis and enable more efficient
treatment.

D.

THE NEED FOR THIS WORK

The main objective of this dissertation is to develop a computer-aided diagnostic (CAD) system for early detection of prostate cancer from both (DCE-MRI)
and (DW-MRI). Non-invasive approaches for prostate cancer diagnosis have been
widely employed, due to their potential to provide superior resolution that plays
an important role in, for example, assessing pathological tissues, locations and extent of the tumor, directing biopsies, planning proper therapy, and evaluating therapeutic results. A generic framework for the analysis of prostate cancer images can
include one or more of the following: (i) segmentation approaches to extract the
prostate, (ii) registration techniques for motion correction, (iii) construction of perfusion curves to distinguish between normal and abnormal tissues, (iv) estimation
of perfusion-related parameters, (v) modeling of the extracted parameters, and
(vi) classification and diagnosis. Since the main steps of any computer-assisted
diagnosis (CAD) system for prostate cancer are image segmentation and image
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registration, below we will briefly overview the popular techniques for image segmentation and registration.

1.

Image Segmentation Methods

Accurate segmentation of the prostate is fundamental for reliable and robust non-invasive analysis of prostate cancer images. Both accuracy and automation of the segmentation technique are of considerable importance. First, automated segmentation is important because it facilitates the complete automation
of the CAD system, minimizes the effect of the operator-dependency, and makes
the diagnosis process reproducible. On the other hand, accuracy of segmentation
is essential for correct diagnosis because many crucial indexes (e.g., features for
discriminating benign and malignant lesions) are based on the contour, shape and
texture of the prostate. These features can be effectively extracted after the desired boundary is correctly detected. Popular prostate segmentation techniques
can be divided into four major categories: (i) rule-based approaches, (ii) statisticalbased approaches, (iii) atlas-based approaches, and (iv) deformable models-based
approaches. A brief overview and the limitations of the existing segmentation approaches are given below.

• Rule-based techniques aim to partition an image into pixels of two or more
values through comparison of pixel values. Most popular approaches are
thresholding, region growing, and region split-and-merge. However, threshold based segmentation approaches are not accurate in the case of gray levels
similarities between the prostate and the surrounding tissues. In addition, region growing-based approaches are sensitive to initialization and often need
user assistance to select proper seed points.
• Statistical-based techniques involves parametric or nonparametric probabil-
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ity models of appearance and shape of goal objects, e.g., Bayesian or maximum likelihood inference. The main limitation of current statistical models
is that the tails of the prostate distributions usually overlap, so it is difficult if
not impossible to find thresholds that separate these objects accurately unless
the object intensities considerably differ from the background. However, this
is generally not the case in prostate images so most of the applications need
more adequate probability models.
• Atlas-based techniques use anatomical atlases that depict prototypical locations and shapes of anatomical structures together with their spatial relations, as reference images to guide segmentation of new images. All the
known atlas-based methods can be classified into single and multi-atlas-based
segmentation. In general, the accuracy of the atlas-based segmentation depends on the accuracy of the atlas-to-target registration (i.e., the segmentation problem is reduced to the registration one). Also, the single-atlas-based
segmentation could suffer from the possibly insufficient representation of the
whole image population. The multi-atlas approach can overcome this drawback, but it requires a large number of atlas-to-target registration steps in
order to produce the final segmentation.

2. Image Registration Methods

The majority of CADs assumes that the prostates (prostate contours) remain
exactly the same from scan to scan. However, prostate contours may not always
exactly match due to patient movement or breathing effects; therefore, accurate
registration of the prostate in MR images is important to precisely analyze the
transit of a contrast agent into the tissue, especially in the suspicious lesions. Accurate registration will also improve spatial correspondence of the prostate region
and provide a one-on-one pixel match in all registered images, thus increasing the
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accuracy of diagnosis. To overcome the above-mentioned limitations, a novel noninvasive MRI-based framework for early diagnosis of prostate cancer is proposed.
The proposed framework performs sequentially the following processing steps.

• Segmentation of the prostate from MR imaging based on a Maximum a Posteriori (MAP) estimate of a new likelihood function that accounts for both
appearance features of the prostate and their 3D spatial voxel interactions ,
as well as a 3D shape prior.
• The integration of image registration approaches (nonrigid techniques), using geometric-based approaches (iso-contours) to improve spatial correspondence of regions-of-interest and provide a one-on-one pixel match in all registered images, thus increasing the accuracy of parameter estimation and/or
diagnosis.
• KNN classifier to classify the prostate into benign or malignant based on
three appearance features extracted from registered image.

E.

DISSERTATION ORGANIZATION

This dissertation consists of six chapters, which can be summarized as follows.

• Chapter I present the background to adequately understand the anatomy of
the prostate, prostate cancer, staging of the prostate cancer, and screening
modalities. In addition, a brief summary of the basic contributions of the
proposed research for diagnosing prostate cancer using DCE-MRI and DWI
are also outlined.
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• Chapter II presents some basic concepts about prostate cancer and medical
images. The current challenges of imaging the prostate in cancer.
• Chapter III presents an overview of the existing computational methods for
diagnosing prostate cancer using MRI and outlines their strengths and weaknesses. Additionally, the state-of-the-art clinical applications and findings
using these computational methods are covered.
• Chapter IV presents a novel, noninvasive framework in prostate application
for early detection of prostate cancer using DCE-MRI.
• Chapter V presents a fully automated image-based framework for early detection of prostate cancer from DWI data.
• Chapter VI presents a general discussion about the presented research and
its results, followed by the main conclusions and the possible areas for future
work.
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CHAPTER II
IMAGING THE PROSTATE IN CANCER

Early detection of prostate cancer is crucial for the accurate diagnosis and
institution of appropriate medical therapies, which can increase the survival rate
of the patients [9]. However, a growing belief that nonlife threatening prostate cancers are being over-detected. Therefore, medical imaging techniques are favorable
since they provide reliable information about the size and shape of the prostate
gland and can localize the cancer foci. which would allow the determination of
efficient treatments and enable more reliable methods of diagnosis and prognostication. Nowadays, medical imaging is a basic component in current medical
diagnostic tools and has demonstrated the proven ability to detect prostate cancer without the associated deleterious side effects of invasive techniques. These
noninvasive methods for prostate cancer diagnosis are based on acquiring scans
of the prostate and analyzing these scans for cancer detection. To acquire scans of
the prostate, different medical imaging techniques, such as Transrectal Ultrasound
(TRUS), Single Photon Emission Computed Tomographic (SPECT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT), have been used (see Figure 7). Each of these image modalities
has its own mechanism for providing relevant physiological information about
the prostate as well as its own advantages and limitations. For example, CT is currently used for post-therapy evaluation by physicians to assess the effectiveness of
treatment. However, it is expensive, uses radiation, and has poor contrast between
soft tissues [19]. The SPECTs used in the detection of metastatic disease and are
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performed when symptoms for disease are present, such as bone pain. PET/CT
allows differentiation between tumor and bowel in pelvis [20], it has limitations to
distinguishing tumors from inflammation. As a result, TRUS and MRI are more
commonly used in CAD systems for diagnosing prostate cancer.

FIGURE 7: Schematic illustration of different medical image modalities for imaging the prostate in cancer.

The Transrectal Ultrasound (TRUS) imaging [21–23] is widely used for guided
needle biopsy due to the real-time nature of the imaging system, ease of use, and
portability (see Figure 8). However, TRUS images have a low signal to noise ratio
(SNR) and detection of malignant tissues is difficult. Although,

(a)

(b)

(c)

FIGURE 8: Different types of prostate medical images: (a) ultrasound image (Courtesy of [8]), (b) computed tomography (CT) image (Courtesy of [7]), and (c) T2 weighted (MRI) image.
Magnetic Resonance Imaging (MRI) has been recently suggested for im-
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proved visualization and localization of the prostate. It provides valuable pathological and anatomical information [24]. Recently, new MRI modalities, such as
Magnetic resonance Spectroscopy (MRS), Dynamic Contrast-Enhanced MRI (DCEMRI), and Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI),
have gained considerable attention as important tools for the early detection of
prostate cancer. However, a side effect is an increase in image data that can be
attributed to a number of factors including: increased image resolution, increased
bits per volume image element (voxel), sampling in an increased number of dimensions, and an increased amount of tissue imaged. Although acquiring additional
data provides a more complete view of the patient’s physiology, it also creates a
quantity of data that may be impossible for a physician to examine. For example,
radiologists have traditionally dealt with only a few 2-D images (such as x-ray radiographs) per exam. However, now the capability exists for doctors to perform
high resolution 3-D MRI scans of a patient. If many of these scans are taken at
different times in order to monitor the progression of the patient’s condition, the
doctor is left with an immense 4-D dataset consisting of hundreds or thousands
of images. Analysis consistency begins to suffer due to inter- and intra-observer
variations. Since all the work presented in this dissertation mainly deals with MRI
prostate data, an overview of different types of the MRI modality is given in the
following section.

A. MAGNETIC RESONANCE IMAGING

Magnetic Resonance Imaging (MRI) has become the most powerful and central noninvasive tool for clinical diagnosis of diseases. The fundamental principle
of MRI is based on the use of a strong static magnetic field in which the hydrogen
nuclei (single proton) of water molecules in human tissues is aligned parallel to
that field. Then, an external radio frequency (RF) pulse (wave) is applied to thun-
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paired magnetic spins (proton) aligned in the static magnetic field, making them
spin in different directions [25]. The interaction between the RF and proton spins
leads to periodic absorption and emission of energy. When the protons relax back
to their lower energy (equilibrium) state, they release detectable signals (energy)
that are spatially encoded and are used to construct the MR image.

FIGURE 9: Different specialized MRI acquisition techniques.

Different types of tissues (muscle, fat, cerebral, spinal fluid, etc.) send back
measurably different types of tissue-specific signals following the application of
the same RF pulse. The contrast of an MR image is strongly dependent on the way
the image is acquired. Different components of the scanned area can be highlighted
using different preselected pulse sequences: strength, shape, and timing of the RF
and gradient pulses (external fields).The most commonly-known specialized MRI
techniques are shown in Figure 9. Generally, MRI can be used to acquire planar
2D images or 3D volumes [25]. Since this dissertation is concerned with building a
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MRI-based CAD system for the early diagnosis of prostate cancer, a brief overview
of the basic principles of is presented in the next section.

1.

Structural MRI

T1 - and -T2 -weighted is a basic type of MRI in which most of the contrast between tissues is due to differences in tissue T2 or T1 values. Usually, T2 -weighted
scans are used when contrast between fluid, abnormalities (e.g., tumors, inflammation, trauma), and the surrounding tissues is required. Therefore, it is the best
MRI method for pathological details (see Figure 8). The T2 -weighted MRI modality has the ability to provide reliable information about the size and shape of the
prostate gland. However, it is limited by unsatisfactory sensitivity and specificity
for cancer detection and localization [26].

2. Dynamic Contrast-Enhanced MRI (DCE-MRI)

Although structural MRI provides excellent soft tissue contrast, it lacks functional information. Dynamic Contrast-Enhanced MRI (DCE-MRI) is a special MR
technique that has the ability to provide superior information about the anatomy,
function, and metabolism of target tissues. The DCE-MRI technique involves acquiring T1-weighted volume images before and at several time points after the injection of a contrast agent. The main role of the DCE-MRI is to increase the image
contrast of anatomical structures (e.g., blood vessels) that are not easily visualized
by the alteration of the magnetic properties of water molecules in their vicinity.
This in turns improves the visualization of tissues, organs, and physiological processes. The DCE-MRI takes advantage of the network of microvascular structures
associated with cancerous tumors. Specifically, the DCE-MRI procedure allows
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for the observation and quantification of vascular permeability and vascular density curves or time-intensity curves as shown in Figure 11. Typical examples of
dynamic MRI time series data of the prostate are shown in Figure 10.

FIGURE 10: MRI Prostate images taken at different time points post the adminstration of the contrast agent showing the change of the contrast as the contrast
agent perfuse into the prostate tissues.

FIGURE 11: (a) A typical time-intensity curve of the average intensity of the
prostate measured before and after contrast agent adminstration. The curve illustrates typical perfusion-related indexes that can be estimated and used for diagnosis of the prostate cancer. (b) Prostate colored by wash-in and wash-out
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3.

Magnetic Resonance Spectroscopy Imaging (MRSI)

Magnetic Resonance Spectroscopy Imaging (MRSI) allows the evaluation of
the metabolic activity within the prostate gland by assessing the quantities of different metabolites. Within the prostate, the most commonly detected metabolites
are choline, creatine, polyamines and citrates. In a healthy prostate, there are low
levels of choline and high levels of citrates; the opposite is observed in patients
with prostate cancer. Polyamines are increased in benign prostatic hyperplasia
and reduced in cancer (see Figure 12). A ratio of choline-plus-creatine to citrate
has been used to help differentiate benign from malignant lesions [27].

FIGURE 12: Examples of MRS. There is a single choline, polyamine, and creatine
peak.

4.

Diffusion-Weighted Imaging (DWI)

DWI is designed to obtain images whose contrast depends on the differences in water molecule mobility. This is achieved during data acquisition by
adding diffusion magnetic field gradients. The degree of diffusion weighting of
the sequence, expressed as the b-factor (in s/mm2 ), depends on the amplitude of
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the field gradient, time of application, and time interval between the magnetic
field gradients. A typical DWI-MRI for the prostate is shown in Figure 13. DWI is
a well-established MRI method that has been successfully used for tumor localization and diagnosis [28].

(a)

(b)
FIGURE 13: Diffusion MR images for the prostate at (a) b-value of 0s/mm2 and (b)
b-value of 800 s/mm2 .

B. QUANTIFICATION OF PROSTATE CANCER USING MR IMAGES

The use of MRI medical images for prostate cancer has been increased in
recent years due to its ability to provide superior anatomical and functional information about the tumor classification. The goal of this work is to evaluate the diagnostic value of an imaging protocol that uses Dynamic Contrast-Enhanced MRI
(DCE-MRI) and Diffusion-Weighted Imaging (DWI) in patients with suspicious
prostate cancer and to determine if additional information, provided by DWI, improves the diagnostic value of prostate MRI [29]. In this dissertation, the proposed
models have been applied to both imaging protocols.
a. Early Detection of Prostate Cancer using (DCE-MRI) The DCE-MRI has
demonstrated the promise for early detection of prostate cancer [30]. The DCEMRI process begins with several MRI scans which are used to establish a baseline
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in image intensity. These scans are performed without the administration of contrast enhancing agents so that the tissue’s non-enhanced image intensity can be
established. In the next stage, a contrast agent (such as Gadolinium) is administered intravenously. At this point, MRI scans are performed at regular intervals.
The contrast agent flows throughout the body, including the tissues being imaged.
Malignant areas of increased microvascular growth have increased vascular leakage; therefore, in these regions more contrast agent passes between the vascular
system and the extravascular tumor tissue [30–32]. The observed dynamics of the
buildup and washout of the contrast agent can help characterize the micro-vessel
density and porosity. Repeated MRI scans continue until the body filters most of
the contrast agent from the blood stream via the kidneys. A signal intensity versus
time curve is created for each voxel in the volume, and local exchange model parameters, inferred from these curves, are used by radiologists to detect and classify
malignant lesions. Currently, manual DCE-MRI analysis is performed using estimated pharmacokinetic parameters which quantify the movement of the contrast
agent into and out of tissues. These parameters are color-coded and superimposed
on a pre-contrast MR image. The radiologists then manually outline the lesions
in the superimposed images using a computer mouse. Once segmented, the average time vs signal intensity plot may be observed and the lesion is classified by
matching the resulting plot with theoretical plots for specific lesion types.
The proposed work in this dissertation seeks to provide a new noninvasive
system that possesses the ability to facilitate the accurate analysis of the perfusion of a CA in the prostate tissue in an effort to extract perfusion parameters that
distinguish between malignant and benign prostate cancers. The innovation in
this case study is a CAD system that integrates stochastic approaches using new
Markov-Gibbs random field (MGRF) energy models and the geometric approaches
to accurately separate the prostate from the surrounding tissues, after handling the
global and local motion, in order to optimally distinguish between malignant and
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benign prostate cancers (see Figure 14).

FIGURE 14: A block diagram of the proposed CAD system for the early diagnosis
of prostate cancer using DCE-MRI. The time series data is first corrected for motion
artifacts. Then, the prostatic tissue is segmented and the agent kinetic curves are
constructed. Finally, perfusion-related parameters are extracted from the kinetic
curves and are used for the classification of both malignant and benign cases.

b. Diffusion-Weighted MRI Diffusion-Weighted MRI (DWI),
a non-invasive technique in which molecular motion of water is measured in biological tissues, is now used in the detection of prostate cancer as an adjunct to
T2 -weighted [33]. The Apparent Diffusion Coefficient (ADC) calculated from DWI
in prostate cancer showed that the mean ADC for malignant prostate is lower than
the mean ADC in the non-malignant prostatic tissue [34–39]. In recent years, a
growing number of clinical studies have evaluated the utility of DWI, either in
combination with or in comparison with other MRI techniques, for the detection
of prostate cancer. These studies have reported various sensitivities and specificities of cancer diagnosis [34, 40–43]. In this dissertation, a comprehensive framework for detection of prostate cancer is proposed based on DWI, see Figure 15.
The proposed diagnostic approach segments the prostate from the surrounding
anatomical structures based on a Maximum a Posteriori (MAP) estimate of a new
log-likelihood function after handling the global and local motions. Then, three
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appearance features are extracted and used for the evaluation of the potential
prostate tumor. In addition, the tumor boundaries are determined using a level
set deformable model controlled by the diffusion information and the spatial interactions between the prostate voxels, see Figure 16.

FIGURE 15: Flowchart of the proposed CAD system for automatic detection of
cancer from 3D DWI. An automatic prostate segmentation method is applied to
isolate the prostate from the surrounding anatomical structures. Following segmentation, a non-rigid registration approach is employed to account for any local
deformation that could occur in the prostate during the scanning process. Three
features are extracted from registered diffusion data. The features are summarized
by a supervised classifier to calculate the likelihood of malignancy.
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FIGURE 16: Pixel-wise parametric map display of the diffusion information and
the spatial interactions between the prostate voxels. The red and blue hues of each
color scale correspond to enhanced and reduced perfusion, respectively.
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CHAPTER III
IMAGE BASED RELATED WORK FOR EARLY DIAGNOSES OF PROSTATE
CANCER

This chapter discusses the developed non-invasive state-of-the-art Computer Aided Diagnosis (CAD) systems for prostate cancer based on analyzing different types of Magnetic Resonance Imaging (MRI), e.g., T2 -MRI, Diffusion
Weighted Imaging (DWI), Dynamic Contrast Enhanced (DCE)-MRI, and multiparametric MRI, focusing on their implementation, experimental procedures, and
reported outcomes. Furthermore, the chapter addresses the limitations of the current prostate cancer diagnostic techniques, outlines the challenges that these techniques face, and introduces the recent trends to solve these challenges. Prostate
segmentation from MRI images, i.e., the delineation of prostate borders from the
surrounding tissues, is a basic step in any noninvasive CAD system for early detection of prostate cancer. However, accurate delineation of prostate borders in MR
images is a challenge due to: large variations of prostate shapes within a specific
time series as well as across subjects; the lack of strong edges and diffused prostate
boundaries; and the similar intensity profile of the prostate and surrounding tissues. Although manual outlining of the prostate border enables the prostate volume to be determined, it is time consuming and observer dependent. Moreover,
traditional edge detection methods [24] are unable to extract the correct boundaries
of the prostate since the gray level distributions of the prostate and the surrounding organs are hardly distinguishable. To overcome this limitation, most successful
known approaches have addressed the segmentation challenges by incorporating
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the prostate appearances and shapes into their segmentation techniques. In particular, an automated framework by Allen et al. [44] was proposed for 3D prostate
segmentation that consists of two steps. voxel classification is performed based
on Gaussian probabilities of grey level. Then, a statistical shape model is used to
segment the prostate region. A hybrid 2D/3D active shape model (ASM)-based
methodology for global optimal segmentation of the 3D MRI prostate data was
proposed by Zhu et al. [45]. Iterative segmentation was performed by a 2D ASM
search on each slice, then the final surface is reconstructed from the 2D search results and updated by re-estimating the parameters of the 3D probabilistic shape
model. Klein et al. [8, 46] presented an atlas-based segmentation approach that
utilized a localized version of mutual information (MI) to extract the prostate from
MR images. The segmentation of the prostate is obtained as the average of the bestmatched registered atlas set to the test image (image to be segmented).Flores-Tapia
et al. [47] proposed a semi-automated edge detection technique for MRI prostate
segmentation. In their framework, the prostate borders were detected by tracing
four manually-selected reference points on the edge of the prostate using a static
Wavelet transform [48] to locate the prostate edges. Toth et al. [49] presented an algorithm for the automatic segmentation of the prostate in multi-modal MRI. Their
algorithm starts by isolating the region of interest (ROI) from MRS data. Then, an
ASM within the ROI is used to obtain the final segmentation. A semi-automated
approach by Vikal et al. [50] used a priori knowledge of prostate shape to detect the
contour in each slice and then refined them to form a 3D prostate surface. Firjani
et al. [51] proposed a MAP based framework that combines a graph-cut approach
and three image features (grey-level intensities, spatial interactions between the
prostate pixels, and a prior shape model) for 2D DCE-MRI prostate segmentation.
Their method was later extended in [52] to allow for 3D segmentation from DCEMRI volumes. It utilized both a 3D MRF to model the spatial interaction between
the prostate voxels and a 3D shape prior.
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An unsupervised segmentation method was proposed by Liu et al. [53] for
the segmentation of MR prostate images. A level set deformable model was employed and was guided by an elliptical prostate shape prior and intensity gradient
was employed to refine the initial results obtained by Otsu thresholding [54]. A
maximum A posteriori (MAP)-based framework was proposed by Makni et al. [55]
to perform automated 3D MRI prostate segmentation. Their framework combined
graylevel, contextual information regarding voxels neighborhoods using MRF, and
statistical shape information to find optimum segmentation based on Bayesian a
posteriori classification, estimated with the iterative conditional mode (ICM) algorithm. Liu et al. [56] proposed an automated approach that utilized fuzzy MRF
modeling for prostate segmentation from multi-parametric MRI. Their framework
exploited T2 -weighted image intensities, pharmacokinetic (PK) parameter kep ,
and apparent diffusion coefficient (ADC) values in a Bayesian approach to label
prostate pixels as cancerous or non-cancerous. The labeled pixels are then clustered using the k-means algorithm. The system had a specificity of 89.58%, sensitivity of 87.50%, accuracy of 89.38%, and a DSC of 62.2%. A similar approach was
developed by Artan et al. [57] and located cancerous regions using cost-sensitive
support vector machine (SVM). Prostate segmentation was performed using a conditional random field and the same three features in [56] were utilized for classification. The DSC for prostate localization and segmentation was 0.46 ± 0.26, and
the area under the receiver operator characteristic (ROC) curves (Az ) of the classification was 0.79 ± 0.12. Ozer et al. [58] also developed a technique that directly
segmented prostate cancers using the same three features in [56, 57]. Both the
SVM and relevance vector machine (RVM) [59] classifiers were used and the system showed a specificity of 0.78 and a sensitivity of 0.74 for RVM and 0.74 and 0.79
for SVM. Gao et al. [60] proposed a shape-based technique that utilized point cloud
registration of the MR images before segmenting the prostate. The final prostate
border is obtained by minimizing a cost functional that incorporated both the local image statistics as well as the learned shape prior. Martin et al. [61] developed
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an atlas-based approach for segmenting the prostate from 3D MR images by mapping a probabilistic anatomical atlas to the test image. The resulting map is used
to constrain a deformable model-based segmentation framework. Recently, Dowling et al. [62] proposed an automated framework that combined dynamic multiatlas label fusion methods. They employed the diffeomorphic demons method for
the nonrigid registration using the selective and iterative method for performance
level estimation (SIMPLE) technique [63]. In their framework, a pre-processing
step for bias field correction, histogram equalization, and anisotropic diffusion
smoothing was employed. Ghose et al. [64] proposed a probabilistic graph-cutbased framework for prostate segmentation based on the fusion of the posterior
probabilities determined with a probabilistic atlas and a supervised random forest
learning framework. An automated technique that first applied global registration
to the prostate MRI data followed by an active appearance model (AAM) based
segmentation of the prostate tissue was proposed by Ghose et al. [65]. Table 2
summarizes the reviewed methodologies for prostate segmentation and registration with the validation data sets and achieved performance for each study. However, in most of these approaches the segmentation and registration reliability is
not very high due to the following reasons: (i) parametric shape models fail in the
presence of large gray-level variability across subjects and time; (ii) edge detection
methods are not suitable for discontinued objects; (iii) deformable models tend to
fail in the case of excessive noise, poor image resolution, diffused boundaries or
occluded objects if they do not incorporate a priori models (e.g., shape and appearance). In addition, most of the motion correction models account only for the
global motion and do not take into account the local motion of the prostate due to
transmitted respiratory and peristaltic effects. Furthermore, the existing local motion correction methods are intensity-based techniques, which are prone to nonlinear intensity variations over the time series and perform poorly in pre-contrast
images. Also, local motion correction methods register the original grey level data
without any prior segmentation; therefore, they do not guarantee voxel-on-voxel
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matches of the registered perfusion data.
The state-of-the-art CAD systems extract several features from MR image
modality for classifying a prostate region as cancerous or noncancerous. Several
CAD systems in the literature have used multi-parametric MRI, a combination of
multiple MRI modalities, to increase the number and quality of the features that
the systems can utilize. A summary of the the common features extracted from
each of these MRI modalities as well as the basic systems along with their computational methods, validation data sets, and validation accuracy are given in Table 3.
To the best of our knowledge, the first semi-automated computerized MRI-based
CAD system for prostate cancer diagnosis was developed by Chan et al [66]. In
their study, multi-modal MRI (T2 −weighted, T2 −mapping, and line scan diffusion
imaging) were used to estimate malignancy likelihood in the PZ of the prostate.
Both statistical maps and textural features were obtained and a SVM and a linear
discriminant analysis (LDA) classifiers were employed for the classification. Their
systems resulted in an Az of 0.761±0.043 and 0.839±0.064, for SVM and LDA respectively. Madabhushi et al [67] proposed an automated CAD system for detecting prostatic adenocarcinoma from MR prostate images. In their method, multiple
image features, including gray levels statistics (intensity values, mean, and standard deviation), intensity gradient, and Gabor filter features, were used for classifying groups of pixels as tumors. A K-nearest neighbor classifier and Bayesian
conditional densities were used for classification, and the system achieved an Az of
0.957. A study by Engelbrecht et al. [68] evaluated which MRI parameters would
result in optimal discrimination of prostatic carcinoma from normal PZ and CZ
of the prostate. Using the ROC curves, their study concluded that the relative
peak enhancement was the most accurate perfusion parameter for cancer detection in the PZ and CZ of the gland. A semiautomated CAD system by Kim et
al. [27] demonstrated that parametric imaging of the wash-in rate was more accurate for the detection of prostate cancer in the PZ than was T2 −weighted imaging
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alone. However, they also observed significant overlap between the wash-in rate
for cancer and normal tissue in the TZ. Fütterer et al. [69] developed a CAD system
to compare the accuracies of T2 −weighted MRI, DCE-MRI, and MRS imaging for
prostate cancer localization. The results showed higher accuracy in DCE-MRI than
were achieved with T2 −weighted MRI in prostate cancer localization. A similar
study was conducted by Rouvièere et al. [70] for the detection of postradiotherapy
recurrence of prostate cancer. Their study also concluded that DCE-MRI possesses
the ability to depict the intraprostatic distribution of recurrent cancer after therapy
more accurately and with less inter-observer variability than T2 − weighted MRI.
Puech et al. [71] developed a semiautomated dynamic MRI-based CAD system
for the detection of prostate cancer. Candidate lesion ROIs were selected either
manually or by using a region growing technique initiated by a user-selected seed
point. Lesions are classified as benign, malignant or indeterminate based on the
analysis of the median wash-in and wash-out values. Their CAD system demonstrated a sensitivity and specificity of 100% and 45% for the PZ, and sensitivity and
specificity of 100% and 40% for the TZ. Ocak et al. [72] developed a CAD system
using PK analysis for prostate cancer diagnostics in patients with biopsy-proven
lesions. In their framework, four PK parameters (K trans , k ep , ve , and the area under the gadolinium concentration curve) were determined and compared for cancer, inflammation, and healthy peripheral. Their results showed improvement in
prostate cancer specificity using the K trans and k ep parameters over that obtained
using conventional T2 −weighted MRI. An automated DCE-MRI CAD system for
prostate cancer detection was proposed by Viswanath et al. [73]. Prostate borders
were segmented using an ASM, and a nonrigid registration scheme (affine and thin
plate spline) was employed to map the whole mount histological sections onto corresponding 2D DCE-MRI. In order to classify prostate tissue, a local linear embedding approach [74] was used to create a feature vector using local neighborhood
intensities. Then, a k-means clustering approach was used for the classification
and the system achieved an accuracy of about 77%. Their framework was later
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extended in [75] by combining T2 − weighted features and DCE-MRI functional
features. The system validation showed that the integration of both modalities
(Az of 0.815) has a better performance of either individual modalities (0.704 for
T2 −weighted MRI and 0.682 for DCE-MRI). A semi-automated framework by Vos
et al. [76] classified prostate lesions using quantitative PK maps and T1 estimates.
PK features were extracted from a user-defined ROI around the prostate and a
SVM was used to estimate the likelihood of malignancy. Based on the ROC analysis, the reported results showed that the system had an accuracy of 83% in the
classification of the ROIs with abnormal enhancement patterns in the PZ. Ampeliotis et al. [77] proposed a semi-automated multi-parametric CAD system that used
T 2 -weighted and DCE-MRI. The T2 −weighted pixel intensities and the four lowfrequency coefficients of the discrete cosine transform were used as features and
probabilistic neural networks were employed as the classifier. Based on the ROC
analysis (Az of 0.898), their study concluded that the fused T2 −weighted and dynamic MRI features outperform that of either modalitys features alone. A similar
CAD system was proposed by Litjens et al. [78] that employed an ASM to segment
the prostate. In order to classify the segmented prostate voxels, the ADC, K trans ,
and k ep parameters were estimated and a SVM classifier with a radial basis function kernel was used. The validation results showed a sensitivity of 74.7% and
83.4% with seven and nine FPs per patient, respectively. Vos et al. [75] utilized
an automated CAD system for the detection of prostate cancer. Just as in [78],
the prostate was segmented using an ASM-based technique. Then, multiple ROIs
were located within the segmented prostate using peak and mean neighborhood
intensity and ADC values. These values and the differences between the peak and
the mean were again used as features for ROI classification. In addition, the 25
percentile T2 , 25 percentile ADC, 25 percentile wash-out, 50 percentile T1 , 75 percentile K trans , and 75 percentile ve were used as features. The resulting feature
vector was classified using an LDA classifier. This system had an Az of 0.830.20. A
maximum Az of 0.88 was reported for high-grade tumors, but the system had dif-
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ficulty classifying lower grade tumors, achieving a maximum Az of 0.74. Another
semi-automated multi-parametric system by Peng et al. [79] utilized T2 −weighted,
DCE-MRI and DWI. Candidate features, including the T 2 -weighted intensity
skew, the K trans , and the average and 10th percentile ADC, were calculated from a
manually-selected ROI. Then, an LDA classifier was used to differentiate prostate
cancer from normal tissue in those ROIs. Their CAD system concluded that the
best diagnostic performance (Az of 0.95 ± 0.02, SEN of 0.82, and SPE of 0.953) is
obtained by combining the 10th percentile ADC, average ADC, and T2 −weighted
intensity skewness features.

TABLE 2: Summary of the discussed prostate segmentation and registration techniques and their experimental performance. Note that DIM and AL stand for data
dimension (i.e., 2D, 3D, or 4D) and the automation level (i.e., automated or semiautomated), respectively.
Study
Allen
et
al. [44]
Klein
al. [46]

et

Zhu
al. [45]

et

FloresTapia
al. [47]
Toth
al. [49]

Klein
al. [8]

et
et

et

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

DIM, AL, and Methods
3D
Automated
ASM-based segmentation
3D
Automated
Affine + B-Splines Registration
Atlas-based segmentation
3D
Automated
Hybrid 2D+3D ASM
3D
Semi-automated
Edge detection
3D
Automated
Unsupervised spectral clustering
ASM-based segmentation
3D
Automated
Affine + B-splines registration
Atlas matching

Data and Performance
• 22 data sets
• MAD: 2.8±0.82
• 38 data sets
• Median DSC: 0.82

• 26 data sets (288 slices)
• RMSD: 5.481±2.91
• 1 data set (19 slices)
• DSC: 0.93±0.005
• 150 slices
• Average OR: 0.83, average
SEN: 0.89, average SPE:
0.86, and average PPV:
0.93
• 50 slices
• Median DSC: 0.85

continued on the next page . . .
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Study
Vikal
et
al. [50]
Makni
al. [55]

et

Liu
al. [53]

et

Ozer et al.
[58]

Artan
al. [57]

et

Liu
al. [56]

et

Gao
al. [60]

et

Martin
al. [61]

et

Dowling et
al. [62]

TABLE 2 – continued from the previous page
DIM, AL, and Methods
Data and Performance
• 3D
• 3 data sets (39 slices)
• Semi-automated
• DSC: 0.93±0.3 and MAD:
• ASM
2.00±0.6 (mm)
• 3D
• 12 data sets
• Automated
• Mean HD: 9.62 (mm), GD:
• ASM
2.39 (mm), OR: 0.84, VPC:
0.90, and DSC: 0.91
• 2D
• 10 data sets
• Automated
• DSC: 0.91±0.03
• Level-set-based
segmentation
• 2D
• 20 data sets
• Automated
• SPE: 0.78, SEN: 0.74, and
• SVM and RVM
DSC: 0.51 for RVM
• SPE: 0.74, SEN: 0.79 and
DSC: 0.52 for SVM
• 2D
• 21 data sets
• Automated
• Az : 0.790±0.12 and DSC:
0.46±0.26
• Cost-sensitive
conditional
random field
• 3D
• 11 data sets
• Automated
• SPE: 0.896, SEN: 0.894,
and DSC: 0.622
• fuzzy MRFs
• 3D
• 48 data sets
• Automated
• DSC: 0.84±0.03 and 95%
• Affine registration
HD: 8.10±1.50 (mm) (33
• Level set segmentation
data sets)
• DSC: 0.82±0.03 and 95%
HD: 10.22±4.03 (mm) (15
public data sets)
• 3D
• 36 data sets
• Automated
• Median DSC: 0.86 and
• Affine + Multi-resolution
Average surface error:
Demons registration
2.41mm
• ASM
• 3D
• 50 data sets
• Automated
• Median DSC: 0.86 and Av• Diffeomorphic demons regiserage surface error: 2.0
tration
(mm)
• Atlas-based segmentation
continued on the next page . . .
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Study
Ghose
et
al. [64]

Ghose
al. [65]

AMM:
ASM:
DSC:
GD:
HD:
MD:
MAD:
N/A:
OR:
OAE:
PPV:
RMSD:
RVM:
SEN:
SPE:
VPC:

et

TABLE 2 – continued from the previous page
DIM, AL, and Methods
Data and Performance
• 3D
• 15 data sets
• Semi-automated
• DSC:
0.91±0.04
and
• Affine + nonrigid Demon
95%HD: 4.69±2.62 (mm)
registration
• Graph-cut segmentation
• 2D
• 15 data sets
• Automated
• DSC: 0.88±0.11;
HD:
3.38±2.81 (mm),
and
• Affine registration
MAD: 1.32±1.53
• AAM-based segmentation
Active appearance model.
Active shape model.
2·TP
Dice similarity coefficient: DSC = 2·TP+FP+FN
where, TP: true positive, FP: false positive, FN: false negative.
Gravity distance.
Hausdorff distance.
Mean distance.
Mean absolute distance.
Not applicable.
Overlap ratio.
FP+FN
Overlapping area error; OAE = TP+FN
%
TP
Positive predictive value; PPV = TP+FP .
Root mean squared distance.
Relevance vector machine.
TP
Sensitivity; SEN = TP+FN
.
TN
Specificity; SPE = TN+FP ; where TN: true negative.
Volume properly contoured.
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TABLE 3: Summary of MRI-based CAD systems for prostate cancer detection and
diagnosis, including segmentation method, selected features, classifier, and experimental performance.
Study
Chan
et
al. [66]
Litjens
al. [78]

et

Technique
T2WI,DWI,
T2 map
DWI,
DCE-MRI,
T2WI

•
•
•
•
•

•
•
Engelbrecht DCE-MRI
et al. [68]

Tiwari
al. [80]

et

T2WI,
MRS

Rouvière et
al. [70]

DCEMRI,T2WI

Kim
al. [27]

DCEMRI,T2WI

et

•
•
•
•
•
•
•
•
•

•
•
•

Madabhushi DCE•
et al. [67]
MRI,T2WI,PD•
•

Features
Manual ROIs
Gabor filter
SVM
ASM
T2 −weighted
intensities,
K trans ,kep ,
and
ADC
Affine + B-Splines
Registration
Atlas-based segmentation
Manual ROIs
time to peak, peak
enhancement,
washout
N/A
Manual ROIs
Random Forest
N/A
Manual ROIs
N/A
Evaluation
and
scoring by three
independent
readers
Manual ROIs
Wash-in rate
A cut-off threshold selected by
a radiologist differentiate cancer
from
normal
tissue
N/A
Gabor filter
Bayes classifier

•
•
•
•

Performance
5 Subjects (33 images)
Az : 0.83±0.064
188 subjects
SEN: 0.747 (at 7 FP
per patient) and
0.834 (at 9 FP per
patient)

• 36 subjects
• Az PZ: 0.79
• Az CZ: 0.70
• 36 subjects
• AU C = 0.79±0.02
• 22 subjects
• ACC: 0.59 (T2 weighted MRI)
• ACC: 0.75 (DCEMRI)
• 53 subjects
• ACC: 0.62 (T2 weighted MRI)
• ACC: 0.88 (DCEMRI)

• 5 data set (33
slices)
• SEN: 0.42, SPE:
0.97 and PPV: 0.43
continued on the next page . . .
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TABLE 3 – continued from the previous page
Study
Technique
Features
Performance
Madabhushi DCE• N/A
• 5 data set (33
et al. [81]
MRI,T2WI • Gabor filter
slices)
• Bayes and kNN- • Az :0.957
nearest neighbor
classifiers
Fütterer et DCE-MRI
• Manual ROIs
• 34 subjects
al. [69]
• wash-out slopes
• Az :0.68
• Prospectively
evaluation
and
scoring of the selected features by
two independent
radiologists
Viswanath
DCE-MRI
• ASM
• 21 subjects
et al. [73]
• Ratio of the wash- • SEN: 60.72%, SPE:
in and wash-out
83.24%, and ACC:
rates
77.2%
• K-means clustering
Ocak et al. T2WI,
• Manual ROIs
• 50 subjects
[72]
DCE-MRI
• the area under • SEN: 0.94, SPE:
the
gadolinium
0.37,
PPV: 50,
concentration
and NPV: 0.89
curve
(T2 -weighted
• Logistic regression
MRI)
modeling
• SEN: 0.73, SPE:
0.88,
PPV:75,
and NPV: 0.75
(DCE-MRI)
Puech et al. DCE-MRI
• Manual ROIs
• 84 subjects
[71]
• Wash-in
and • for PZ SEN: 100%
wash-out slopes
and SPE: 45%
• Automatic scoring • for TZ SEN: 100%
algorithm
and SPE: 40%
Vos
et DCE-MRI, • Manual ROIs
• 34 subjects
• Quantitative
• Az :0.83
al. [76]
T2WI
features
were
extracted from a
kinetic modelling
of the enhancement curve
• SVM
continued on the next page . . .
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Study
Ampeliotis
et al. [77]

Viswanath
et al. [82]

Lopes et al.
[83]

Shah et al.
[84]

TABLE 3 – continued from the previous page
Technique
Features
Performance
T2WI,
• Manual ROIs
• 10 subjects
DCE-MRI
• T2 -weighted fea- • Az :0.89
(T2 tures
(intensity,
weighted
MRI)
and the intensity
and (DCE-MRI)
variance)
• Probabilistic neural networks
DCE-MRI
• ASM
• 6 subjects (18 Im• T2 features (stanages)
dard
deviation, • Az :0.815 ± 0.029
gradient, Haralick
feature), and DCE
features (washin
and wash-out)
• Bayes
classifier
and random forest
DWI
• Manual ROIs
• 17 subjects
• Fractal
dimen- • SEN: 0.83 and SPE:
sion, and Multi0.91 for AdaBoost
fractional Brown- • SEN: 0.85 and SPE:
ian motion
0.93 for SVM
• SVM and AdaBoost
T2WI,
• K-means
• 24 subjects
DWI,
• T2
intensities • F-M: 0.93, Raters
DCE-MRI
and Quantitative
agreement
features
were
(Kappa): 0.89
extracted from a
kinetic modelling
of the enhancement curve and
ADC
• SVM
continued on the next page . . .
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Study
Sung et al.
[85]

Vos
al. [75]

et

Niaf et al.
[86]

Peng et al.
[79]

AMM:
ASM:

TABLE 3 – continued from the previous page
Technique
Features
Performance
DCE-MRI
• Manual ROIs
• 42 subjects
• T2 baseline and • SEN: 0.77, SPE:
peak signal in0.77, and ACC:
tensities,
initial
0.83
up-slope, washin and washout
rates, time to peak,
percentage of relative enhancement,
percentage
enhancement ratio,
time of arrival
• SVM
DWI,
• ASM
• 200 subjects
DCE-MRI
• T2
intensities • SEN: 0.41 (at 1
and Quantitative
FPs), 0.65 (at 3
features
were
FPs), and 0.74 ( at
extracted from a
5 FPs)
kinetic modelling
of the enhancement curve and
ADC
• LDA
T2WI,
• Manual ROIs
• 30 subjects
DCE-MRI, • T2
Quantitative • Az :0.89
DWI
features
were
extracted from a
kinetic modelling
of the enhancement curve
• Nonlinear SVM,
LDA,
kNNnearest neighbor,
and naı̈ve Bayes
classifiers
T2WI,
• Manual ROIs
• 48 subjects
DCE-MRI, • T2
Quantitative • Az :0.95 ± 0.02
DWI
features
were
extracted from a
kinetic modelling
and ADC
• LDA
Active appearance model.
Active shape model.
continued on the next page . . .
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AAC:
SVM:
LDA:
F-M:
IAUC:
ADC:
DSC:
GD:
HD:
MD:
MAD:
N/A:
OR:
OAE:
PPV:
RMSD:
RVM:
SEN:
SPE:
VPC:

TABLE 3 – continued from the previous page
Technique
Features
Performance
TP+TP
Accuracy: ACC = TP+FP+FN+TN
where, TP: true positive, FP: false positive, TN: true negative.
Support vector machine.
Linear discriminate analysis
F-Measure.
Initial area under the time-concentration curve.
Apparent diffusion coefficient.
2·TP
Dice similarity coefficient: DSC = 2·TP+FP+FN
where, TP: true positive, FP: false positive, FN: false negative.
Gravity distance.
Hausdorff distance.
Mean distance.
Mean absolute distance.
Not applicable.
Overlap ratio.
FP+FN
Overlapping area error; OAE = TP+FN
%
TP
Positive predictive value; PPV = TP+FP .
Root mean squared distance.
Relevance vector machine.
TP
Sensitivity; SEN = TP+FN
.
TN
Specificity; SPE = TN+FP ; where TN: true negative.
Volume properly contoured.

In summary, developing noninvasive CAD systems for the detection and
diagnosis of prostate cancer is an area of research interest. Current CAD systems focus mainly on the initial voxel classification stage by obtaining likelihood
maps that combine information from MR images using mathematical descriptors.
State-of-the art studies showed that voxel basis discrimination between benign
and malignant tissue is feasible with good performances. However, the majority of these studies were performed by radiologists who selected an ROI (small
window) around the prostate and followed signal changes within these ROIs. In
addition, the final diagnosis and patient management is left to the radiologist. Unfortunately, such approaches not only require manual interaction of the operators,
but also ROI selection biases the final decision and brings up the same issue of
over- or under-estimating the problem in the entire gland, just as with biopsy.
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Moreover, manual ROI selection and function curve generation from these ROIs
assume that the prostates (prostate contours) remain exactly the same from scan to
scan. Nonetheless, prostate contours may not always exactly match due to patient
movement or breathing effects; therefore, motion correction techniques should be
applied first before ROI selection. Also, to automate the algorithm and to cancel
ROI dependency, segmentation approaches that can separate the prostate from the
surrounding structures are needed.
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CHAPTER IV
A NOVEL IMAGE-BASED APPROACH FOR EARLY DETECTION OF
PROSTATE CANCER USING DCE-MRI

This chapter presents a novel non-invasive approach for early diagnosis
of prostate cancer from dynamic contrast enhanced magnetic resonance imaging
(DCE-MRI). In order to precisely analyze the complex 3D DCE-MRI of the prostate,
a novel processing frame work that consists of four main steps is proposed. The
first step is to isolate the prostate from the surrounding anatomical structures
based on a Maximum a Posteriori (MAP) estimate of a log-likelihood function that
accounts for the shape priori, the spatial interaction, and the current appearance
of the prostate tissues and its background (surrounding anatomical structures).
In the second step, a non-rigid registration algorithm is employed to account for
any local deformation that could occur in the prostate during the scanning process
due to the patient’s breathing and local motion. In the third step, the perfusion
curves that show propagation of the contrast agent into the tissue are obtained
from the segmented prostate of the whole image sequence of the patient. In the final step, we collect two features from these curves and use a kn -Nearest Neighbor
classifier classifier to distinguish between malignant and benign detected tumors.
Moreover, in this chapter, we introduce a new approach to generate color maps
that illustrate the propagation of the contrast agent in the prostate tissues based
on the analysis of the 3D spatial interaction of the change of the gray level values
of prostate voxels using a Generalized Gauss-Markov Random Field (GGMRF)
image model. Finally, the tumor boundaries are determined using a level set de-
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formable model controlled by the perfusion information and the spatial interactions between the prostate voxels. Experimental results on 30 clinical DCE-MRI
data sets yield promising results.

A.

INTRODUCTION

Neoangiogenesis is the key component of the development of prostate cancer, composed of increases in both the density and permeability of blood vessels
within the cancerous area [87, 88]. These microvascular alterations result in differences in the enhancement pattern of prostate cancer compared with benign
prostate tissue when performing Dynamic Contrast-Enhanced MRI (DCE-MRI).
These differences are multifactorial and include earlier and more intense enhancement as well as more rapid washout of contrast material within the tumor [89].
Studies have shown dynamic contrast enhancement to improve the performance
of MRI for the localization of prostate cancer, raising the sensitivity for tumor in
comparison with either T2 -weighted imaging alone. This in turn contributes to
a role for DCE-MRI in directing prostate biopsy [88] as well as in preoperative
staging and surgical planning [69, 90]. DCE-MRI poses multiple challenges stemming from the need to image very quickly, to capture the transient first-pass transit
event, while maintaining adequate spatial resolution. Other factors such as varying signal intensities over the time course of agent transit also complicate segmentation procedures. Nonrigid deformations, or shape changes, may occur related to
pulsatile or transmitted effects from adjacent structures, such as bowel.
Most prostate CAD researchers [27, 68–71, 76] have focused on the initial
voxel classification stage. They obtained likelihood maps by combining information from MR images using mathematical descriptors. These studies showed on
a voxel basis that the discrimination between benign and malignant tissue is fea-
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sible with good performances. However, these studies require user interaction to
select a ROI around the prostate. In addition to the localization of the ROI of the
tumor, the final diagnosis and patient management is left to the radiologist. However, the majority of these studies were performed by radiologists who selected a
region of interest (ROI) (a small window) around the prostate and followed signal change within this region of interest. Unfortunately, such approaches not only
require manual interaction of the operators, but also ROI selection biases the final decision and brings up the same issue of over or underestimating the problem
in the entire graft, just as with biopsy. Moreover, manual window selection and
generating a function curve from this window over a time-sequence of images, assumes that the prostates (prostate contours) remain exactly the same from scan to
scan. However, prostate contours may not always exactly match due to patient
movement or breathing effects; therefore, image registration schemes should be
applied first before ROI selection. Also, to automate the algorithm and to cancel
ROI dependency, segmentation algorithms that can separate the prostate from the
surrounding structures are needed. To overcome these limitations, we propose an
automatic framework for the early diagnosis of prostate cancer using DCE-MRI.
The proposed framework segments the prostate from the surrounding
anatomical structures based on a MAP estimate of a new likelihood function. To
handle the object inhomogeneities and variability and overcome image noise, the
proposed likelihood function accounts for the visual appearances of the prostate
and background, 3D spatial interaction between the prostate voxels, and a learned
3D shape model. Second, in order to account for any local prostate deformations
that could occur during the scanning process, a nonrigid registration algorithm is
employed, which is based on deforming a target prostate object over evolving isocontours to match a reference object. The correspondences between the target and
reference objects are found by the solution of the Laplace equation as described in
Section IV.B.2 In the third step, agent kinetic curves that show the contrast agent
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propagation into the tissue are obtained, and then used to collect two features
to distinguish between malignant and benign detected tumors using a kn -nearest
neighbor classifier. Finally, parametric map displays that illustrate the propagation
of the contrast agent into the prostate tissue are constructed for visual assessment
and characterization of the physiological data. Details of the proposed framework
are described in the following sections.

B. Methods

In this chapter we introduce a new, automated, and noninvasive framework
for early diagnosis of prostate cancer by analyzing 3D DCE-MRI time series perfusion data is proposed see Figure 17. In the proposed DCE-MRI based framework,
the classification of prostate cancer is performed using the following five steps:

1. Segmentation of the prostate objects from the surrounding abdominal structures on the DCE-MR images.
2. Nonrigid registration for local motion correction.
3. Distinguish between malignant and benign detected tumors.

The overall framework has been tested on a total of 30 dynamic DCE-MRI perfusion data sets to permit us to draw statistically meaningful inferences

1.

Segmentation of the Prostate Using a Joint MGRF Model

The segmentation of the prostate is a challenge, since the gray-level distribution of the prostate and surrounding organs is not highly distinguishable and
because of the anatomical complexity of prostate. This stage proposes a power-
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FIGURE 17: The proposed CAD system for early detection of prostate cancer

ful framework for prostate segmentation based on a learned shape model and an
identifiable joint Markov-Gibbs Random Field (MGRF) model of DCE-MRI and
”object-background” region maps. The joint-MGRF model is fundamentally a
model that relates the joint probability of an image and its object-background region map, to geometric structure and to the energy of repeated patterns within the
image. The basic theory behind such models is that they assume that the signals
associated with each pixel depend on the signals of the neighboring pixels, and
thus explicitly take into account their spatial interactions, and other features, such
as shape.
Let Q = {0, . . . , Q − 1}, L = {ob, bg}, and U = [0, 1] be a set of Q integer
gray levels, a set of object (“ob”) and background (“bg”) labels, and a unit interval,
respectively. Let a 3D arithmetic grid R = {(x, y, z) : x = 0, 1, . . . , X − 1; y =
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0, 1, . . . , Y − 1; z = 0, 1, . . . , Z − 1} support grayscale DCE-MRI g : R → Q and
their binary region maps m : R → L, and probabilistic shape model s : R → U.
The shape model allows for registering (aligning) 3D prostate DCE-MRI. The DCEMR data g and its region maps m are described with a joint probability model:

P (g, m) = P (g|m)Ph (m)

(1)

where P (g|m) is a conditional distribution of the images given the map and
Ph (m) = Ps (m)P (m) is an unconditional probability distribution of maps. The
map model Ph (m) = Ps (m)P (m) has two independent parts: a shape prior being
a spatially variant independent random field of region labels Ps (m), for a set of
co-aligned training DCE-MR data, and a 2nd -order MGRF model P (m) of spatially
homogeneous evolving map m.
The Bayesian MAP estimate of the map, given the MR data g,
m∗ = arg max L(g, m) maximize the log-likelihood function:
m

L(g, m) = log(P (g|m)) + log(Ph (m))

(2)

In this work we focus on accurate identification of the spatial interaction
between the prostate voxels (Ph (m), and the intensity distribution for the prostate
tissues, (P (g|m)), as shown in Figure.18.
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FIGURE 18: Illustration of the Joint Markov-Gibbs random field (MGRF) image
model of the prostate DCE-MRI.
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To perform the initial prostate segmentation, a given 3D DCE-MR images
is aligned to one of the training 3D DCE-MR images. The shape model provides
the voxels-wise object and background probabilities being used, together with the
conditional image intensity model P (g|m), to build an initial region map. The final
Bayesian segmentation is performed using the identified joint MGRF model of the
DCE-MRI and region maps.
a. Conditional Intensity Model

The specific visual appearance of the

prostate in each data set to be segmented is taken into account by modeling a
marginal gray level distribution with a linear combination of discrete Gaussians
(LCDG) [91–93]. Unlike the conventional modeling with a mixture of Gaussians [94]
or other simple distributions [95], one per dominant mode, we accurately approximate the empirical signal distributions with a linear combination of sign-alternate
discrete Gaussians, and partition the LCDG for the whole image into sub-models
relating to each dominant mode, i.e. the prostate and the background.
A discrete Gaussian (DG) Ψθ = (ψ(q|θ) : q ∈ Q) is defined as a discrete
probability distribution with Q components obtained by integrating a continuous
1-D Gaussian density φ(q|θ) with parameters θ = (µ, σ), where µ is the mean
and σ 2 is the variance, over Q intervals related to the successive signal values
∫q
in Q: if Φθ (q) = −∞ φ(z|θ)dz is the cumulative Gaussian probability function,
then ψ(0|θ) = Φθ (0.5), ψ(q|θ) = Φθ (q + 0.5) − Φθ (q − 0.5) for q = 1, . . . , Q − 2,
and ψ(Q − 1|θ) = 1 − Φθ (Q − 1.5). The LCDG, Pw,Θ = [pw,Θ (q) : q ∈ Q];
∑
q∈Q pw,Θ (q) = 1, with two positive dominant and multiple positive, Cp ≥ 2,
and negative, Cn ≥ 0, DGs subordinate is defined as follows [92]:
pw,Θ (q) =

Cp
∑

wp:k ψ(q|θp:k ) −

k=1

Cn
∑

wn:l ψ(q|θn:l )

(3)

l=1

with the non-negative weights w = [wp:k , wn:l ] that meet the obvious constraint
∑Cp
∑Cn
k=1 wp:k −
l=1 wn:l = 1. The subordinate DGs approximate closely the deviations of the empirical distribution from the conventional mixture of the dominant
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positive DGs.
Given the number K of the dominant DGs (in our particular case K = 2),
the numbers Cp − K and Cn of the subordinate components, as well as the parameters w, Θ (i.e., the weights, the means, and the variances) of all the DGs are
estimated first with a sequential initializing expectation maximization (EM) based
algorithm producing a close initial LCDG-approximation of the empirical distribution. Then, under the fixed numbers of the components, Cp and Cn , all the other
parameters are refined with an EM algorithm, modified to account for the signalternate components [96]. The refined LCDG model is finally partitioned into
two LCDG sub-models, one per class, by associating the subordinate DGs with
the dominant components in such a way that the misclassification rate is minimal.
The LCDG of Equation 3, including the numbers Cp and Cn of its components, is
identified using the expectation-maximization (EM)-based algorithm introduced
in [97–103].
b. Spatial Voxel Interaction Model To overcome the noise effect and to ensure the homogeneity of the segmentation, spatial voxel interactions between the
region labels are also taken into account using a generic MGRF of the region map.
A generic MGRF of region maps [96, 104] accounts only for 2D pairwise interaction
between each region label and its characteristic neighbors. Generally, the interaction structure and the Gibbs potentials can be arbitrary and are identified from
the training data. For simplicity, we restrict the interaction structure to the nearest
voxel 26- neighborhood only as shown in Figure. 19. By symmetry considerations,
we assume that the potentials are independent of relative orientation of each voxel
pair and depend only on intra- or inter-region position (i.e. whether the labels are
equal or not). Under these restrictions, it is the 3D extension of the conventional
auto-binomial, or Potts model differing only in that the potentials are estimated
analytically.
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FIGURE 19: 3D 2nd order MGRF neighborhood system. Note that the reference
voxel is shown in red and d represents the absolute distance between two voxels
in the same and adjacent MRI slices, or cross-sections.

The 26-neighborhood has three types of symmetric pairwise interactions
specified by the absolute distance a between two voxels in the same and adja√
√
cent MRI slices (a = 1, 2, and 3, respectively): (i) the closest pairs with the
inter-voxel coordinate offsets N1 = {(1, 0, 0), (0, 1, 0), (0, 0, 1)}; (ii) the farther diagonal pairs with the offsets N√2 = {(0, 1, ±1), (1, 0, ±1), (1, ±1, 0)}, and (iii) the
farthest diagonal pairs with the offsets N√3 = {(1, ±1, ±1)}. The potentials of each
type are bi-valued because only the coincidence of the labels is taken into account:
Va = {Va,eq ; Va,ne } where Va,eq = Va (l, l′ ) if l = l′ and Va,ne = Va (l, l′ ) if l ̸= l′ ;
√ √
a ∈ A = {1, 2, 3}. Then the MGRF model of region maps is as follows:

P (m) =

1
exp
Z

∑

∑

∑

Va (mx,y,z , mx+ξ,y+η,z+κ )

(x,y,z)∈R a∈A (ξ,η,κ)∈Na

where Z is the normalizing factor (partition function).
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(4)

To identify the MGRF model described in the equation, approximate analytical maximum likelihood estimate of the 3D Gibbs potentials, Va,eq , Va,ne are derived
in line with [91, 96, 105].
Va,eq = −Va,ne

(
)
1
= 2 fa,eq (m) −
2

(5)

where fa,eq (m) denotes the relative frequency of the equal label pairs in the equivalent voxel pairs {((x, y, z), (x+ξ, y +η, z +κ)): (x, y, z) ∈ R; (x+ξ, y +η, z +κ) ∈ R;
(ξ, η, κ) ∈ Na }. of a region map m of a given DCE-MRI aligned in accord with the
prior shape model.
c. Probabilistic Shape Model To enhance the segmentation accuracy, additional constraints based on the expected shape of the prostate are introduced
by co-aligning each given DCE-MR data to a training database and using a soft
probabilistic 3D prostate shape model To circumvent this limitation, we use a soft
∏
probabilistic 3D prostate shape model Ps (m) = (x,y,z)∈R Smx,y,z ; where Smx,y,z is
the empirical probability that the voxel (x, y, z), belongs to the prostate (L = ob)
or the background (L = bg) given the map (see Figure.21). The soft template (see
Figure.22) is constructed and updated as outlined in Algorithm IV.B.1.c and the
proposed prostate segmentation process can be summarize as in Algorithm IV.B.1.c
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(a)

(b)

(c)
FIGURE 20: Forming the prostate shape prior onto 2D: (a) training samples, (b)
manually segmented prostate regions, and (b) their affine MI-based alignment.
Note that the registration enhances the overlap between the prostate objects and
thus reduce the variability of the final estimated shape.

(a)

(b)

(c)

FIGURE 21: 3D prostate shape model projected onto 2D axial (a), saggital (b), and
coronal (c) planes for visualization.
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(a)

(b)

FIGURE 22: Gray-coded (a) and color-coded (b) axial view of the prostate shape
prior. initial region map. The final Bayesian segmentation is performed using the
identified joint MGRF model of the DCE-MRI data and its region maps. In total,
the proposed prostate segmentation approach involves the steps summarized in
Algorithm IV.B.1.c

56

Algorithm 1 3D Prostate Shape Model
Initialization
• Co-align the 3D MRI training sets collected from different subjects using
a rigid 3D registration maximizing their mutual information (MI) [106].
• Manually segment the prostate from the aligned sets.
• Estimate the voxel-wise probabilities by counting how many times each
voxel (x, y, z) was segmented as the prostate.
Updating Prior Shape Model:
• To enhance the segmentation of the current prostate volume, the prior
probabilistic shape model is updated by adding the previous segmented
3D prostate data to the prior calculated shape model.
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Algorithm 2 Prostate Segmentation Approach
Input: 3D DCE-MRI prostate data g to be segmented.
Output: segmented prostate border (the final estimate m).
• Training Phase:
1. Co-align the 3D DCE-MRI training sets collected from different subjects using a rigid 3D registration maximizing their mutual information (MI) [106].
2. Manual delineation of the prostate borders from the co-aligned data
3. Estimate the voxel-wise probabilities by counting how many times
each voxel (x, y, z) was segmented as the prostate.
• Testing Phase:
1. Perform an affine alignment of a given 3D DCE-MRI to an arbitrary
prototype prostate from the training set using MI [106] to obtain the
learned probabilistic shape model Ps (m).
2. Estimate the conditional intensity model P (g|m) by identifying the
bimodal LCDG.
3. Use the intensity model that is estimated using LCDG and the
learned probabilistic shape model to perform an initial segmentation (initial region map) of the prostate.
4. Use the initial region map to estimate the potential for the Potts
model using Equation (5) and to identify the MGRF model P (m)
of region maps.
5. Improve the region map using voxel-wise stochastic relaxation (Iterative conditional mode-ICM [107]) through successive iterations
to maximize the log likelihood function of Equation (2) until the log
likelihood remains almost the same for two successive iterations.
6. Update the Shape Prior: by adding the current segmented 3D
prostate data to the prior calculated shape model.
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2.

Nonrigid Registration

Due to patient breathing and local movement, accurate registration is a main
issue in DCE-MRI sequences. A tremendous number of nonrigid image registration techniques have been developed, e.g., [60, 63]. However, more robust, efficient, and sophisticated registration techniques are required. In order to avoid
problems associated with intensity variations over the temporal dynamic contrast
agent data set, the proposed approach exploits geometric features, rather than image intensities. These geometric features are estimated from the electric field vectors that are calculated by solving the Laplace second-order PDE between the segmented prostate borders. Estimating these field vectors allow for co-allocation of
point-to-point correspondences between the segmented prostate objects. Mathematically, the second-order Laplace PDE defines a scalar field γ, defined as:

∇2 γ =

∂ 2γ ∂ 2γ
+
=0
∂x2 ∂y 2

(6)

The solution γ(x, y) of Equation (6) results in intermediate equipotential surfaces and streamlines (field lines) that are everywhere orthogonal to all equipotential surfaces and establish natural point-to-point correspondences between the
boundaries (see e.g., the line connecting the points Bai and Bbj in Figure. 24). In
medical imaging applications, the Laplace-based approaches have been previously
used e.g., for colon surface flattening and centerline extraction [108] and thickness
measurements [109–111]. To the best of our knowledge, the Laplace-potentialbased method is the first of its kind to be applied to the motion correction in
DCE-MRI images for further improved analysis of the DCE-MRI data. The proposed Laplace-based nonrigid registration approach is based on deforming each
pixel of the segmented prostate objects over a set of nested, equi-spaced contours
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(i.e., iso-contours), which is generated for both the target and reference prostate
objects as shown in Figure 23. To find the iso-contours, a distance map is generated inside the binary object area by finding the minimum Euclidean distance for
every inner point to the object boundary. The external points are excluded from
consideration. Then, the Laplace equation is applied to the respective reference
and target iso-contours to co-locate their corresponding points. The basic steps
of the Laplace-potential-based nonrigid registration are summarized in Algorithm
IV.B.2.

(a)

(b)

(c)

(d)

(e)

(f)

FIGURE 23: Illustration of the iso-contours generation: the reference (a) and target
(d) images, the reference (b) and target (e) distance maps, and reference (c) and
target (f) iso-contours.
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Algorithm 3 Laplace-Based Iso-Contours Nonrigid Registration
Input: segmented prostate objects.
Output: point-to-point correspondences.
1. Generate the distance maps inside the segmented prostate as shown in Figure 23 (b, e).
2. Generate nested, iso-contours for both target and reference distance maps as
shown in Figure. 23 (c, f).
3. Initial condition: Set the potential γ maximum at the target iso-contour and
minimum (equal zero) at the reference iso-contour.
4. Solve Eq. (6) between respective iso-contours using the above initial condition.
5. Compute components of the gradient vectors Ex =

∂γ
∂x

and Ey =

∂γ
.
∂y

6. Find the point-to-point correspondences between the iso-contours being
matched by forming the streamlines.
7. Repeat steps 3 to 6 for the next set of corresponding iso-contours.
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FIGURE 24: 2-D schematic illustration of co-allocation of the point-to-point correspondences between two boundaries by a potential field.
3.

Classification, Performance Analysis, and Visualization of Perfusion Indexes

After the nonrigid alignment, the wash-in and wash-out curves are constructed by calculating the average intensities of prostate regions for each time
sequence. These curves show the response of the prostate tissues as the contrast
agent perfuses for each image section (see Figure 32).
a. Color Map Generation and Tumor Boundary Determination To characterize the physiological data, color-coded maps that illustrate the propagation of the
contrast agent in the prostate tissues are constructed. To construct the initial color
maps, we have to estimate the changes in image signals δx,y,z due to the contrast
agent. These changes are estimated from the constructed perfusion curves as the
difference between the signals of image sequences at tp and t0 (see Figure. 25).
To preserve continuity (remove inconsistencies), the initial estimated δx,y,z
values are considered as samples from a Generalized Gauss-Markov Random Field
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FIGURE 25: Estimating δ from the perfusion curve as the difference between the
peak and initial signal of image sequences.

(GGMRF) image model of measurements with the 26-voxel neighborhood (Figure 18). Continuity of the constructed 3-D volume (Figure 26) is amplified by using
their Maximum a Posteriori (MAP) estimates as shown in [112]:

δbx,y,z = arg min
δex,y,z







β

α

δx,y,z − δex,y,z

∑

α β

+ρ λ

η(x,y,z),(x′ ,y′ ,z′ ) δex,y,z − δx′ ,y′ ,z′

(x′ ,y ′ ,z ′ )∈ν(x,y,z)

where δx,y,z and δex,y,z denote the original values and their expected estimates, ν(x,y,z)
is the 26-neighborhood voxel set (Figure 18), η.,. is the GGMRF potential, and ρ and
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FIGURE 26: Enhanced perfusion estimation and continuity analysis using the 3D
GGMRF image model.

λ are scaling factors. The parameter β ∈ [1.01, 2.0] controls the level of smoothing (e.g., smooth, β = 2, vs. relatively abrupt edges, β = 1.01). The parameter
α ∈ {1, 2} determines the Gaussian, α = 2, or Laplace, α = 1, prior distribution of
the estimator. Then, the color maps are generated based on the final estimated δb
(see Figure 33).
Finally, to allocate the boundary of the detected tumors, which is important
to determine the cancer stage in case of malignancy, we used a level set-based deformable model controlled by a stochastic speed function [113]. The latter accounts
for the perfusion information and spatial interactions between the prostate voxels.

C. PERFORMANCE EVALUATION AND VALIDATION

To evaluate the performance of the proposed framework, we used two types
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of error metrics, the voxel-based and distance-based errors. To calculate the voxelbased error, we measure the True Positive (TP), True Negative (TN), False Positive
(FP), and False Negative (FN) segmentation. Let |C|, |G|, and |g| denote volumes
(by the number of voxels) of the segmented volume, C, its ground truth, G, and
the MR data, g, respectively. Then TP = |C ∩ G| is the overlapping between C and
G; TN = |g − C ∪ G|; FP = |C − C ∩ G|, and FN = |G − C ∩ G|.
The Dice similarity coefficient (DSC) measures set agreement between two
sets C, G and is defined as the union size of the two sets divided by the average
size of the two sets:

DSC(C, G) =

2|C ∩ G|
C∩G+C∪G

(7)

We calculate the Positive Predictive Value (PPV), Sensitivity (Sens), and Dice
Coefficient (DSC) - as defined as [114]:

=

TP
T P +F P

Sens =

TP
T P +F N

DSC =

2∗T P
2∗T P +F P +F N

PPV
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(8)

FIGURE 27: 2-D schematic illustration of measuring segmentation errors between
the ground truth G and automatic segmentation C obtained by the our segmentation approach.

D. PATIENT DATA AND DCE-MRI ACQUISITION PROTOCOL

The performance of the proposed segmentation approach is evaluated by
applying it on 3D DCE-MRI prostate images. We observed that good selection of
a DCE-MRI imaging protocol is as important as the image analysis. The protocol
described below has been found to be optimal with the current MRI hardware
(Signa Horizon LX Echo speed; General Electric Medical Systems, Milwaukee, WI,
USA).
In our protocol, gradient-echo T1 imaging was employed by a Signa Horizon GE 1.5 Tesla MR scanner using an additional pelvic coil. Images were taken
at 7 mm thickness with an interslice gap of 0.5mm. The repetition time (TR) was
50ms, the TE was minimum with flip angle at 60◦ degrees, the band width was
31.25 kilohertz (kHz), the field of view (FOV) was 28cm, and the number of slices
was 7. The DCE-MRI process started with a series of MRI scans which were used
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to establish a baseline in image intensity. These scans were performed without
the administration of contrast enhancing agents so that the tissue’s nonenhanced
image intensity could be established. In the next stage, 10 cubic centimeter (cc)
of gadoteric acid (Dotarem 0.5 millimole/milliliter (mmol/mL); Guerbet, France)
was administered intravenously at a rate of 3mL/s. At this point, a series of MRI
scans was performed every 3 seconds for 6 minutes, and every series contained 7
slices. Note that all the subjects were diagnosed using a biopsy (ground truth).

1.

Prostate Segmentation Results

The proposed segmentation approach has been tested on DCE-MRI
sequences for 30 independent subjects. Figure 28 demonstrates some segmentation results of the prostate region at selected image sections for different subjects
and their associated False Positive (FP) and False Negative (FN) errors. For comparison, our segmentation results are compared to the radiologists tracing based
on the Positive Predictive Value (PPV), Sensitivity (Sens), and Dice Similarity Coefficient (DSC) [114] statistics for the proposed approach are summarized in Table
4. To highlight the advantage of integrating the shape prior with the intensity and
spatial interaction information in the joint MGRF probabilistic model, we segment
the prostate region based only on the intensity and spatial interaction information.
The segmentation results are shown in Figure 29 (d). It is clear that counting on
intensity and spatial interaction information only will not lead to accurate segmentation due to the gray-levels inhomogeneities.
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FIGURE 28: Segmentation results: the segmentation results with error referenced
to the ground truth G is outlined in yellow (False Negative (FN): pixels segmented
as the prostate in G but not segmented as the prostate with our approach) and red
(False Positive (FP): pixels segmented as the prostate with our approach but not
segmented as the prostate in the G .
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TABLE 4: Error statistics of the proposed segmentation approach. Note that SD,
stands for standard deviation.

Mean±SD

PPV

SEN

DSC

0.98±0.004

0.846±0.004

0.923±0.004

TABLE 5: Comparative segmentation accuracies of the proposed prostate segmentation against the shape-based (SB) approach [2] in comparison to the experts
ground truth (SD standard deviation).
Segmentation Technique

Mean±SD

Proposed Approach

Shape-based(SB) approach [2]

0.53±0.33

5.91±4.44

Two-tailed P-value

0.0001

To show the advantage of the proposed segmentation approach, all time
series images have been segmented using the shape-based approach proposed in
Tsai et al. [2]. The comparative results for a few of them are shown in Figure 30.
Table 5 compares the segmentation results over all test data sets with the known
ground truth (manual tracing by an imaging expert) and the differences are shown
to be statistically significant by the unpaired t-test (the two-tailed value P is less
than 0.0001).
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(a)

(b)

(c)

(d)

FIGURE 29: Segmentation results of the first subject after 30 iteration: (a) typical
prostate DCE-MRI images. (b) the ground truth (c) segmentation results by intensity, shape prior, and spatial interaction (d) segmentation results by intensity, and
spatial interaction only.
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FIGURE 30: Accuracy of our segmentation in comparison with [2]. Our segmentation is outlined in blue and [2] in red with reference to the ground truth G in
white.
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2.

Diagnostic Results

The ultimate goal of the proposed framework is to successfully distinguish
malignant from benign detected tumors by constructing the perfusion curves from
the DCE-MRI sequences (see Figure 31).

FIGURE 31: Estimation of the perfusion parameters for the classification of
prostate tumor (a) Dynamic sequence showing prostate-averaged voxel intensity
versus time, along with images at three different time (b) Prostate colored by washin and wash-out.
The curves on Figure 32 show the response of the prostate tissues as the
contrast agent perfuses. The malignant subjects show an abrupt increase to the
higher perfusion values and the benign subjects show a delay in reaching their
peak perfusion (see Figure 32).
From these curves, we conclude that the peak signal value and the washin slope are the two major features that can be extracted for the classification of
prostate cancer. To distinguish between benign and malignant cases, a kn -Nearest
Neighbor classifier is used to learn the statistical characteristics of both benign and
malignant cases from the time-intensity curves of the training sets (see Figure 32).
The diagnostic accuracy of the kn classifier was 98% using Leave One-Subject-Out
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FIGURE 32: Selected normalized signal intensity, averaged over the entire
prostate, with respect to the timing of contrast agent delivery for malignant (red)
and benign (blue) subject.

(LOSO) approach.
Following the classification, a visual assessment is made. Figure 33 presents
the color-coded maps over all image sections before and after applying the 3-D
GGMRF smoothing for three subjects involved in our study. Figures 34 and 36
show two examples of the tumor contours, determination for benign and malignant subjects.
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FIGURE 33: Color-coded maps for four of the test subjects before and after the 3-D
√
GGMRF smoothing with ρ = 1, λ = 5, β = 1.01, α = 2, and ηs,r = 2 and their
respective color-coded maps. The red and blue ends of the color scale relate to the
maximum and minimum changes, respectively.
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FIGURE 34: Color-coded maps of local tumor progression overlaid on anatomic
DCE-MRI data for one benign subject. The determined tumor contours are shown
in blue.
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FIGURE 35: Color-coded maps of local tumor progression overlaid on anatomic
DCE-MRI data for one benign subject. The determined tumor contours are shown
in blue.
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FIGURE 36: Dynamic contrast-enhanced MRI images of the pelvis with local tumor progression of malignant subject. The determined tumor contours are shown
in blue.
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FIGURE 37: Dynamic contrast-enhanced MRI images of the pelvis with local tumor progression of another malignant subject. The determined tumor contours are
shown in blue.
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E. SUMMARY

In this chapter, we presented a noninvasive MRI-based CAD for detecting
prostate cancer. The proposed framework demonstrated the documented ability
to reliably distinguish malignant from benign, in a biopsy-proven preliminary cohort of 30 participants. The proposed framework includes prostate segmentation,
nonrigid registration, and kn -Nearest Neighbor based classification. For prostate
segmentation, we introduced a new 3D approach that is based on a MAP estimate
of a new log-likelihood function that accounts for the shape priori, the spatial interaction, and the current appearance of the prostate tissues and its background.
Following segmentation, we introduced a nonrigid registration approach that deforms the prostate object on iso-contours instead of a square lattice, which provides
more degrees of freedom to obtain accurate deformation. The perfusion curves of
the segmented prostate region are calculated and the features extracted from these
curves undergo kn -Nearest Neighbor based classification. Applications of the proposed approach yield promising results that would, in the near future, replace the
use of current technologies to determine the type of prostate cancer. The work presented in this chapter has been published in the IEEE International Symposium on
Biomedical Imaging (ISBI), [52], Computational Intelligence in Biomedical Imaging [30], and the Medical Image Computing and Computer-Assisted Intervention
(MICCAI) conference [51]
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CHAPTER V
A NOVEL IMAGE-BASED APPROACH FOR EARLY DETECTION OF
PROSTATE CANCER USING DIFFUSION-WEIGHTED MRI

This chapter introduces a fully automatic non-invasive approach for the
early diagnosis of prostate cancer using Diffusion-Weighted MRI (DWI). The proposed diagnostic approach consists of the following four steps to detect locations
that are suspicious for prostate cancer: 1) In the first step, we isolate the prostate
from the surrounding anatomical structures based on a Maximum A Posteriori
(MAP) estimate of a new log-likelihood function that ac- counts for the shape priori, the spatial interaction, and the current appearance of prostate tissues and its
background (surrounding anatomical structures); 2) In order to take into account
any local deformation between the segmented prostates at different b-values that
could occur during the scanning process due to local motion, a non-rigid registration algorithm is employed; 3) A kn -Nearest Neighbor classifier is used to classify
the prostate into benign or malignant based on three appearance features extracted
from registered images; and 4) The tumor boundaries are determined using a level
set deformable model controlled by the diffusion information and the spatial interactions between the prostate voxels. Experimental results on in vivo data confirm
the accuracy and robustness of our method.
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A.

INTRODUCTION

Earlier studies [40] have investigated the abilities of DWI for prostate cancer
diagnosis using an endorectal coil. However, the reported results demonstrated
low diagnostic sensitivity [115]. To increase the sensitivity of diagnosis, Shimofusa
et al. [34] suggested the addition of strong magnetic field gradient pulses (b-values)
to the pulse sequence instead of using an endorectal coil. In their study [34], they
detected the tumor in the central zone of the prostate in five of eight total patients
using DWI with strong magnetic field gradient pulses. Alternatively, the compared
diagnostic results with T2 -weighted imaging, detected the tumor only in one of
the eight patients. Since then, DWI were used for the detection of cancerous tissue
in later studies [36, 38, 39, 41, 116] . For example, Tan et al. [116] compared the
performance of T2 -weighted MRI, DCE-MRI, and DWI for the detection of cancer
within the prostate gland. In their study, they reported that DWI alone showed
better specificity than DCE-MRI alone. It is also showed better overall specificity
than combined DWI and T2 -weighted imaging. To the best of our knowledge,
there is a very limited number [38, 41] of image-based approaches for automated
computer-aided diagnosis of prostate cancer using DWI. Therefore, there is a need
for developing new methods for automated computer-aided diagnosis of prostate
cancer using DWI.

B. MATERIALS AND METHODS

In this section we introduce automated and non-invasive framework for
early diagnosis of prostate cancer using DWI. Figure 38 demonstrates the steps of
the proposed CAD system. Below, we will illustrate each of these steps.
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FIGURE 38: Flowchart of the proposed CAD system for automatic detection of
cancer from 3D DWI.

1.

Delineation of the Prostate Borders

The segmentation of the prostate from DWI is a challenge due to the anatomical complexity of the prostate and the undistinguishable gray-level distribution of
the prostate and surrounding organs. To account for these challenges, a MAPbased approach based on a learned shape model and an identifiable joint MarkovGibbs random field (MGRF) model is proposed. The proposed MGRF image model
relates the joint probability of an image and its object-background region segmentation map, to geometric structure and to the energy of repeated patterns within
the image [117]. The basic theory behind such models is that they assume that the
signals associated with each voxel depend on the signals of the neighboring voxel,
and thus explicitly take into account their spatial interaction, and other features,
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such as shape.
The input 3D DWI data g and its region map m are described by the joint
MGRF model as outlined in Section IV.B.1, Equation 1. The Bayesian MAP estimate
of the map, given g, m∗ = arg max L(g, m) maximize the log-likelihood function:
m

L(g, m) = log(P (g|m)) + log(Ph (m))

(9)

where P (g|m) is a conditional distribution of the images given the map m
and P (m) = Psp (m)Pv (m) is an unconditional probability distribution of maps.
Here, Psp (m) denotes the prostate shape prior, and Pv (m) is a Gibbs probability
distribution with potentials V , which specifies a MGRF model of spatially homogeneous maps m.
The specific visual appearance of the prostate in each data set to be segmented is taken into account by modeling the marginal gray level distribution
with the LCDG model [91–93] as described in Section IV.B.1.a. To overcome noise
effect and to ensure the homogeneity of the segmentation, the spatial voxel interactions between the region labels of a given map m are also taken into account using
the pairwise MGRF spatial model as described in Section IV.B.1.b and the nearest
voxel 26-neighbors shown in Figure 39.
In addition to voxel-wise image intensities and their pairwise spatial interaction, additional constraints based on the expected shape of the prostate are
introduced by co-aligning each given DWI data to a training database and using
probabilistic 3D prostate shape model Psp (m). To perform initial prostate segmentation, a given 3D DWI is aligned to one of the training data. The shape model provides the voxel-wise object and background probabilities being used together with
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FIGURE 39: 3D 2nd order MGRF neighborhood system. Note that the reference
voxel is shown in red and a represents the absolute distance between two voxels
in the same and adjacent MRI slices, or cross-sections
the conditional image intensity model P (g|m), to build an initial region map. The
final Bayesian segmentation is performed using the identified joint MGRF model
of the DWI data and its region maps. Finally, the proposed prostate segmentation
approach involves the steps summarized in Algorithm V.B.1.

2.

Nonrigid Registration

The nonrigid registration of the DWI data of different b-values is performed
by solving the second-order linear partial differential Laplace equation as described
in Section IV.B.2. For completeness, the main steps of the Laplace-based nonrigid
registration is summarized in Figure 40 as follows:

1. Generation of the distance maps inside the prostate regions (Figure 40 (a,b)).
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Algorithm 4 Key Steps for prostate Segmentation
1. Input: The 3D DWI prostate data g to be segmented.
2. Construct the shape prior from the training data.
3. Approximate the marginal intensity distribution by the linear combinations
of discrete Gaussians (LCDG) with two dominant modes.
4. Form an initial region map m using the estimated LCDG model.
5. Find the Gibbs potentials for the Markov-Gibbs random field (MGRF) model
from the initial map.
6. Improve the region map using voxel-wise stochastic relaxation (Iterative conditional mode-ICM [107]) through successive iterations to maximize the log
likelihood function of Equation (9) until the log likelihood remains almost
the same for two successive iterations.
7. Output: The 3D prostate segmentation is the final estimate region map, m.

2. Generation of the iso-contours using distance maps in step 1 in (Figure 40 (c,d)).
3. Solution of the Laplace equation between respective reference and target isocontours to co-allocate the corresponding points.

3. Diffusion Characterization and Tumor Boundary Determination

To characterize the physiological data, color-coded maps that illustrate the
propagation o of diffusion in the prostate tissues are constructed. To construct the
initial color maps, we have to estimate the changes in image signals δx,y,z due to the
Brownian motion. These changes are estimated from the constructed normalized
diffusion as the difference between the signals of image sequences at two differ-
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FIGURE 40: Illustration of the iso-contours generation: the reference and target
distance maps (a, b), and their iso-contours (c, d).
ent b-values. DWI is performed with at least two b-values, including a b-value of
0s/mm2 and a higher b-value of 500 − 1000s/mm2 depending on the body region
or organ being imaged [118]. At b = 0s/mm2 , there is no diffusion sensitizing gradient with free water molecules have high signal intensity. We used b = 800s/mm2
because imaging of solid organs requires high b-value specially in prostate and using high b-values allows differentiation of areas of restricted from the normal high
signal at the peripheral zone. During our trials we found the b = 800s/mm2 allows
lesions differentiation with least degradation of image quality as the image quality
decrease with the high b-values. To preserve continuity (remove inconsistencies),
the initial estimated δx,y,z values are considered as samples from a Generalized
Gauss-Markov Random Field (GGMRF) image model [112] of measurements with
the 26-voxel neighborhood . Continuity of the constructed 3-D volume is amplified
by using their MAP estimates [92]:
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δbx,y,z = arg min
δex,y,z







α

δx,y,z − δex,y,z

+ ρ α λβ
β

∑

η(x,y,z),(x′ ,y′ ,z′ ) δex,y,z − δx′ ,y′ ,z′

(x′ ,y ′ ,z ′ )∈ν(x,y,z)






where δx,y,z and δex,y,z denote the original values and their expected estimates, ν(x,y,z)
is the 26-neighborhood voxel set, η.,. is the GGMRF potential, and ρ and λ are scaling factors (Figure 41. The parameter β ∈ [1.01, 2.0] controls the level of smoothing (e.g., smooth, β = 2, vs. relatively abrupt edges, β = 1.01). The parameter
α ∈ {1, 2} determines the Gaussian, α = 2, or Laplace, α = 1, prior distribution of
the estimator. Then, the color maps are generated based on the final estimated δb
(see Figure 42).

FIGURE 41: Enhanced perfusion estimation and continuity analysis using the 3D
GGMRF image model.

Finally, locate the boundary of the detected tumors (see Figure 43), which
is important to determine the cancer stage in case of malignancy, we used a level
set-based deformable model controlled by a stochastic speed function [119]. The
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FIGURE 42: Color-coded maps for three of the test subjects (column wise) before
and after the 3-D GGMRF smoothing. The red and blue ends of the color scale
relate to the maximum and minimum changes, respectively.

latter accounts for the diffusion information and spatial interactions between the
prostate voxels.
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FIGURE 43: Pixel-wise parametric map display of the diffusion information and
the spatial interactions between the prostate voxels. The red and blue hues of each
color scale correspond to enhanced and reduced perfusion, respectively.

C.

1.

EXPERIMENTAL RESULTS

Patients and Data Acquisition

The performance of the proposed framework has been evaluated by applying it on DWI prostate images collected from 30 patients. These patients had
biopsy-proven prostate cancer and underwent DWI at 1.5 T (SIGNA Horizon, General Electric Medical Systems, Milwaukee, WI). a DWI was then obtained using
mono-directional gradients and a multi-section Fast Spin Echo type (FSE) echoplanar sequence in the axial plane using a body coil with the following imaging
parameters: TE : 84 : 6ms; TR : 8.000ms; Band Width 142 kilohertz (kHz); field-ofview (FOV) was 34cm; slice thickness was 3mm; inter-slice gap 0mm; seven excitations, water excitation with b-value of 0s/mm2 and 800 s/mm2 . Fifty-four slices
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TABLE 6: Error Statistics over all test data sets.

Mean±SD

PPV

SEN

DSC

0.952±0.004

0.816±0.004

0.991±0.004

were obtained in 120 seconds to cover the prostate in each patient. Note that all
the subjects were diagnosed using a biopsy (ground truth).

2.

Segmentation Results

The proposed segmentation approach has been tested on DWI sequences
for 30 independent subjects. Figure 44 shows some segmentation results of the
prostate region at selected image sections for different subjects and their associated false positive (FP) and false negative (FN) segmentation errors, with respect
to the ground truth segmentation. The ground truths were obtained by manual delineation of the prostate borders by an MR imaging expert. The positive predictive
value (PPV), sensitivity (SEN), and Dice similarity coefficient (DSC) statistics for
the proposed approach are summarized in Table 6. To highlight the advantage of
the proposed segmentation approach, all time series images have been segmented
using the shape-based (SB) approach proposed by Tsai et al. [2]. The comparative results for a few of them are shown in Figure 45 and Table 7 summarizes the
segmentation error statistics of the proposed approach and the SB approach with
respect to ground truth. The differences between the mean errors of the proposed
approach and the SB approach are shown to be statistically significant by the unpaired t-test (the two-tailed value P is less than 0.0001).
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FIGURE 44: Segmentation result and their associated FN (green) and FP (red) errors referenced to the ground truth G.
3.

Diagnostic Results

The ultimate goal of the proposed framework is to distinguish between benign and malignant detected tumors. The malignant tissues show higher signal
intensity with a b-value of 800s/mm2 , and a lower Apparent Diffusion Coefficient
(ADC) compared with benign and normal tissue due to the replacement of normal tissue. To distinguish between the benign and malignant cases, we used a
kn -Nearest Neighbor classifier to learn statistical characteristics of the DWI. The
characteristics are obtained from the training sets containing both benign and malignant cases. After training, three features, which are the mean intensity value of
the DWI at 0s/mm2 , the mean intensity value of the DWI at 800 s/mm2 , and the
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TABLE 7: A Comparative segmentation accuracy over all test data sets for our
approach and [2]. Note that STD stands for standard deviation.
Eavg %
Our approach

[2]

Min. Error%

0

0

Max. Error%

1.6005

2.7724

Average Error% 0.5500

1.4675

STD %

0.7687

0.3085

P-value

0.001

TABLE 8: Area under the ROC curve for training subjects, testing subjects, and
combined (training and testing subjects).
Area Under ROC Curve
Training Subjects

Az = 0.996

Test Subjects

Az = 0.964

All Subjects

Az = 0.985

mean value of ADC maps [120], were chosen to classify the test cases. To build the
kn classifier that characterizes the prostate tissue, we used 20 subjects for training,
and the other 10 subjects for testing.
Overall system performance is demonstrated in Figure 46. For each of these
ROC curves, performance is measured in comparison with the classification produced by the biopsy. Table 8 lists the area under the Receiver operating characteristic (ROC) curve performance for the ROC curves shown in Figure 46.
For regional display, we explored pixel-by-pixel maps of the registered dif-
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FIGURE 45: 3-D prostate segmentation projected onto 2-D. (a) 2-D visualization for
our segmented prostates for three of the test subjects, (b) our segmentation (red)
in comparison with the ground truth (white), and (c) the segmentation with the
algorithm in [2] (red) comparison with the ground truth.

fusion data. The diffusion was computed for each pixel and superimposed on an
image slice to form a parametric image. Also, for visual assessment of the prostate
tumor, the tumor contours were determined. Figure 47 (c) shows the diffusion
map for selected image sections for four subjects involved in our study.
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FIGURE 46: Receiver operating characteristic curves for training subjects, testing
subjects, and combined (training and testing subjects). CAD performance is with
respect to classification produced by the expert.
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FIGURE 47: Diffusion MR images for the prostate at (a) b-value of 0s/mm2 , (b) b
value of 800 s/mm2 , and (c) tumor progression for four of the test subjects.
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D.

SUMMARY

In this chapter, we presented a novel fully automatic framework for detecting prostate cancer using DWI. The framework includes prostate segmentation,
nonrigid registration, and KNN-based classification. For prostate segmentation,
we introduced a new 3D approach that is based on a MAP estimate of a new loglikelihood function that accounts for the shape priori, the spatial interaction, and
the current appearance of the prostate and its background which increases the accuracy of automatic segmentation, evidenced by the error and the DSC analysis
(Tables 7 and 6). Following segmentation, we used a nonrigid registration approach that deforms the prostate object on iso-contours instead of a square lattice,
which provides higher degrees of freedom to obtain accurate deformation. In the
classification step, the segmented prostate regions are classified into malignant or
benign using the kn classifier. Applications of the proposed framework can assist
the radiologist in detecting all prostate cancer locations and could replace the use
of current technologies to determine the type of prostate cancer. The work presented in this chapter has been published in the IEEE International Conference on
Image Processing (ICIP), [42], Journal of Biomedical Science and Engineering [33],
and the Biomedical Science and Engineering Conference (BSEC) [29].
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CHAPTER VI
CONCLUSIONS AND FUTURE WORK

The work presented in this dissertation documents the ability of DCE-MRI
and DWI to distinguish between the benign and malignant prostate tumor cases.
The key main advantage of the proposed computer-aided diagnostic (CAD) system for distinguishing between the benign and malignant cases is the ability of the
developed motion correction model to provide accurate pixel-on-pixel matches of
the registered images for generating and displaying parametric maps. These capabilities are of great importance for the radiologists to help investigate, in the case
of cancer, in which local regions need attention and follow-up with appropriate
treatment. We give a summary of the main contributions of this dissertation is as
follows:

• A novel 3D prostate segmentation approach is proposed. The proposed approach is based on a Maximum a Posteriori (MAP) estimate of a log-likelihood
function that accounts for three image features: the higher-order spatialinteraction between the image pixels, prior probabilistic shape model, and
first-order visual appearance of the prostate. These three features are integrated into a two level joint Markov-Gibbs random field (MGRF) model of
the prostate and its background. As demonstrated in the experimental results, the DSC for extracting the prostate is 93.34 ± 0.004%, which confirms
the high accuracy of the proposed prostate segmentation approach.
• An unsupervised probabilistic model to learn the second- and higher-order
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spatial interactions between the object pixels (voxels) from medical images is
proposed. The model possesses the ability to account for the appearance features to learn the inhomogeneity in the prostate. The proposed model adds
to the pairwise the higher-order spatial interactions between region labels of
a given segmentation.
• An adaptive probabilistic shape model that has the ability to learn both the
shape of the prostate and the subject-to-subject variability is proposed. The
adaptive shape model has been successfully used to guide the classification
of prostate cancer and has shown an ability to account for the complexity of
the prostate shape. The results of this model confirm its benefits and encourage using it to model other medical structures.
• A nonrigid registration to compensate for local object deformations caused
by physiological effects is proposed. The proposed nonrigid registration deforms each pixel of the target object over a set of nested, equi-spaced contours
(i.e., iso-contours) to closely match the reference object, by exploiting the geometric features, rather than image intensities to avoid problems associated
with nonlinear intensity variations in the prostate.

Several possibilities for the future work of this dissertation include, but are
not limited to, the following:

• Investigating the fusion between DCE-MRI and DWI. This fusion is expected
to give better diagnosis results of the prostate cancer.
• Investigating the integration of the proposed work with the BioImaging lab
work for the detection of brain disorders such as autism [121–152] and dyslexia
[153–165].
• Testing the proposed mathematical models and learning techniques in other
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clinical studies, such as detection of lung cancer [166–207] , early detection of
acute renal rejection [113, 208–230], and cardiac MRI [111, 119, 231–245]
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APPENDIX I

A. LIST OF ABBREVIATIONS

The following convention is used throughout the dissertation.
1D

One-Dimensional.

2D

Two-Dimensional.

3D

Three-Dimensional.

4D

Four-Dimensional.

ACC

Accuracy.

ADC

Apparent Diffusion Coefficient.

AIF

Arterial Input Function.

AAM

Active Appearance Model.

CA

Contrast Agent.

CAD

Computer-Assisted Diagnosis.

CE

Contrast-Enhanced.

CE-CT

Contrast-Enhanced Computed Tomography.

CT

Computed Tomography.

CTA

Computed Tomography Angiography.

DCE-CT

Dynamic ContrastEnhanced Computed Tomography.

DCE-MRI

Dynamic ContrastEnhanced Magnetic Resonance Imaging.

DG

Discrete-Gaussian.

DCT

Discrete Cosine Transform.
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DSC

Dice similarity coefficients.

DTI

Diffusion Tensor Image.

DWI

Diffusion-Weighted Image.

ECF

Extracellular Fluid Space.

EM

expectation Maximization.

fMRI

Functional Magnetic Resonance Imaging.

FN

False Negative.

FP

False Positive.

FOV

Field of View.

GGMRF

Generalized Gauss-Markov Random Field.

ICA

Independent Component Analysis.

LCDG

Linear Combinations of Discrete Gaussians.

MGRF

Markov Gibbs Random Field.

MI

Mutual Information.

MRI

Magnetic Resonance Imaging.

MRA

Magnetic Resonance Angiography.

MRS

Magnetic Resonance Spectroscopy.

MRSI

Magnetic Resonance Spectroscopy Imaging.

NCC

Normalized Cross-Correlation.

NGF

Normalized Gradient Field.

NMI

Normalized Mutual Information.

PDE

Partial Differential Equation.

PDMD

Phase Difference Movement Detection .

PET

Positron Emission Tomography.

PK

Pharmacokinetic.

PPV

Positive Predictive Value.

PWI

Perfusion-Weighted Images.

PZ

Peripheral Zone.
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ROC

Receiver Operating Characteristic.

ROI

Region-of-Interest.

RF

Radio Frequency.

SD

Standard Deviation.

SPECT

Single Photon Emission Computed Tomography.

SEN

Sensitivity.

SNR

Signal-to-Noise Ratio.

SPE

Specificity.

SVM

Support Vector Machine.

TIC

Time-Intensity Curve.

TN

True Negative.

TZ

Transition Zone.

TP

True Positive.

TRUS

Transrectal Ultrasound.

US

Ultrasound.
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APPENDIX II

A. NOMENCLATURE

The following convention is used throughout the dissertation

• T1 is the spin-lattice (longitudinal) relaxation time of an MRI scan.
• T2 is the spin-spin (transverse) relaxation time of an MRI scan.
• K trans is the volume transfer constant of the contrast agent from the blood
plasma to the interstitial space.
• Kep is the reverse transfer constat of the contrast agent from the interstitial
space to the blood plasma.
• (x, y)-denotes the cartesian coordinates of points (pixels) in the image plane.
• t denotes the continuous time.
• τ denotes a time step.
• n denotes a discrete time instant.
• ∇=

[

∂
, ∂, ∂
∂x ∂y ∂z

]
is the differential Operator.

• Vn (x, y) is the deformable model speed function at each pixel location.
• Q is the number of gray levels.
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• Q = {0, . . . , Q − 1} denote sets of gray levels q.
• K = {1, . . . , K} denotes sets of region labels k.
• R denotes a 2-D (x,y)- arithmetic lattice.
• m denote binary region maps.
• g denote gray level images.
• K is the number of image modes (number of classes).
• P (g, m) is a joint two-level probability model of a gray scale images and their
region maps.
• P (g|m) is a conditional distribution of images, given the map.
• Ps (m) is an unconditional probability distribution of maps.
• Psp (m) is shape prior probability of region maps.
• p(q) is the estimated density for the mixed gray level distribution.
• p(q|k) is the estimated marginal density for a class k.
• ψ(q|θ) is a Gaussian density with a shorthand notation θ ≡ (µ, σ 2 ) for its
mean, µ, and variance, σ 2 .
• Φθ (q) is a cumulative Gaussian probability function with a shorthand notation θ = (µ, σ 2 ) for its mean, µ, and variance, σ 2 .
• Cp is the number of positive Gaussian kernel for the estimated mixed density.
• Cn is the number of negative Gaussian kernel for the estimated mixed density.
• wp,. is the mixed weight of positive Gaussian kernel.
• wn,. is the mixed weight of negative Gaussian kernel.
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• a is the Euclidean distance between two pixel locations.
• A = {1,

√ √
2, 3} denotes a set of Euclidean distances.

• N is the neighborhood system.
• |CN | is the cardinality of the neighborhood system.
• Z is the normalizing factor or partition function.
• Va = {Va,eq , Va,eq } denotes the Gibbs potentials.
• fa,eq (.) denotes the relative frequency of the equal label pairs in the equivalent
pixel pairs in a certain neighborhood.
• ξ is the shift in x-direction.
• η is the shift in y-direction.
• Ω1:x,y is the combined shape, spatial, and intensity probabilities of the object.
• Ω0:x,y is the combined shape, spatial, and intensity probabilities of the background.
• κ is the contour curvature.
• γ denotes a scalar field.
• Ex is the gradient vector in x-direction.
• Ey is the gradient vector in y-direction.
• G denotes the expert, ground truth segmented region.
• C denotes the model segmented region.
• Az denotes the area under the curve.
• Π denotes a lattice of control points.
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• ⌊ε⌋ denotes the integer part of a real-valued number ε.
• (s, t): s = x − ⌊x⌋ ∈ [0, 1) and t = y − ⌊y⌋ ∈ [0, 1), is the relative position of the
cartesian point (x, y) with respect to the four nearest lattice points (u, v), (u +
1, v), (u, v + 1), (u + 1, v + 1)
• βj (.), j = −1, . . . , 2, is the uniform cubic B-spline basis function.
• C(., .) is the similarity metric between the reference and target images.
• H(.) is the Shannon’s entropy of the image signals.
• H(., .) is the joint entropy of the image signals.
• N is the number of images in the training data.
• α is the shape model mixing weights.
• ρ is the normalized cross correlation.
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